data_1rly_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rly _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.213 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.632 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.213 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.795 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.798 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 44' ' ' ARG . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.795 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.271 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.918 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.271 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.126 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.786 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.918 ' HA ' ' O ' ' A' ' 32' ' ' MET . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.319 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.588 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.598 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 1.0 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.015 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.319 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.128 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.742 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 1.015 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.0 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HD2' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 46' ' ' ILE . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.785 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.167 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.733 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.167 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.16 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.802 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.557 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 41' ' ' VAL . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 40' ' ' VAL . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' ILE . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' CD ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' O ' ' CG2' ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.16 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.899 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.73 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.16 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.134 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.829 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.783 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.899 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.719 0.295 . . . . 0.0 111.221 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.795 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.192 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.656 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.779 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.755 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.192 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.798 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 32' ' ' MET . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.447 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 56' ' ' SER . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.706 0.288 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.166 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 HD23 ' HG ' ' A' ' 39' ' ' LEU . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.148 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.166 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.809 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.428 ' CG2' HG21 ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.797 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.253 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.489 HG23 ' HA ' ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.803 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.803 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.253 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.143 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.792 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.596 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' MET . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.8 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.23 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CD1' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.02 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 1.02 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.666 ' HB ' ' HA ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.23 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.098 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.808 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.882 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.612 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.799 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 ' CG2' HG13 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 16' ' ' PRO . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.139 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 23' ' ' LEU . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.879 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.139 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.729 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.82 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.879 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.759 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.889 0.376 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.771 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.133 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' MET . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.797 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.113 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.133 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.805 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.617 ' CD1' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 32' ' ' MET . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 40' ' ' VAL . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 2.1 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.333 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.421 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.251 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.588 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 22' ' ' ILE . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.616 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.251 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.049 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.788 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.485 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.786 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.15 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' O ' ' CG2' ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.682 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.961 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.595 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.088 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.15 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.824 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.822 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.529 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.228 ' NE2' ' SG ' ' A' ' 34' ' ' CYS 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.716 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.683 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.996 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.886 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.996 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.228 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.016 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.787 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.942 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ILE 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.666 ' O ' ' CG2' ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.666 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.269 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.68 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.78 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.849 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.849 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.78 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.518 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.269 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.097 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.809 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.823 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.679 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 32' ' ' MET . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.694 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.694 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.814 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 15' ' ' CYS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.296 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.692 HG23 ' HA ' ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.593 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.731 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.805 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.764 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.296 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.114 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.796 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.129 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.626 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 HD12 ' SG ' ' A' ' 15' ' ' CYS . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.114 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.129 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.825 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.602 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 40' ' ' VAL . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' ILE . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.6 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.793 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.209 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.594 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.6 ' HA ' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.999 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.812 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.999 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.209 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.123 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.803 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.838 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG21 ' A' ' 40' ' ' VAL . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' H ' HG21 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.565 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.33 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.764 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 1.015 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.663 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.33 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.165 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.773 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.015 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.284 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.639 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.62 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.62 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.284 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.122 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.809 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.831 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.611 HD13 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' MET . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.611 HG22 HD13 ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.802 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.276 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.551 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.578 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.741 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.578 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.739 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.907 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.276 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.092 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.802 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.794 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.907 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG2' ' C ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.734 0.302 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.65 HG21 HG23 ' A' ' 22' ' ' ILE . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.792 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.303 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.7 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.775 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.877 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.303 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.149 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.811 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.629 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.433 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.786 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.111 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.696 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD23 ' HG ' ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.804 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.592 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.094 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.111 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.813 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 32' ' ' MET . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 40' ' ' VAL . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.603 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.248 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 33' ' ' ILE . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.844 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.864 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.768 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.248 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.118 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.805 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.844 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 32' ' ' MET . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.545 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.663 0.268 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.401 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 1.195 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.672 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 32' ' ' MET . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' TYR . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.768 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 1.195 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 1.089 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.804 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.883 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 40' ' ' VAL . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.537 HG12 ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' HG12 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -88.07 54.66 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.8 p -120.8 34.82 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.36 -170.42 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -108.15 -74.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tp -108.98 126.74 53.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -153.78 48.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.28 -55.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.38 64.54 3.56 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.449 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.06 66.98 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.783 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.16 -151.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.798 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.213 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.632 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.698 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.213 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.71 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.798 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.518 ' H ' ' HB3' ' A' ' 44' ' ' ARG . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.908 0.385 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -123.82 2.06 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.397 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 p -125.09 3.51 7.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.386 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.55 156.82 19.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.15 -65.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.89 48.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.81 -72.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.2 130.99 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -80.61 -50.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 94.2 Cg_endo -81.1 160.56 20.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.428 2.085 . . . . 0.0 112.418 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -177.98 4.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.51 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.126 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.918 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.789 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.126 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.918 ' HA ' ' O ' ' A' ' 32' ' ' MET . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.331 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -113.59 47.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -150.81 75.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 t -162.74 153.65 17.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.726 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.15 -70.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 173.22 40.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 77.2 -54.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.84 164.51 36.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.177 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.429 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -111.02 -55.29 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.594 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 48.9 Cg_endo -87.92 -80.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.433 2.089 . . . . 0.0 112.922 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 170.41 21.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.448 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.659 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.128 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.588 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 1.0 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.015 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.885 ' O ' ' N ' ' A' ' 38' ' ' GLY . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.128 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.662 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 1.015 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.0 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.823 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HD2' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 46' ' ' ILE . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.92 0.391 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.97 -32.27 14.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 p -85.82 -29.57 23.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.6 t -58.38 134.4 56.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -69.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -177.3 125.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.44 128.09 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.78 177.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.978 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -88.91 -51.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 97.5 Cg_endo -87.64 -166.41 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.669 2.246 . . . . 0.0 112.379 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -125.49 -90.79 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.63 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.557 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.16 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.733 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.705 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.805 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.16 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 39' ' ' LEU . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.557 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.763 ' O ' HG22 ' A' ' 41' ' ' VAL . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 40' ' ' VAL . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 46' ' ' ILE . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -95.02 18.79 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.89 28.64 7.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 110.803 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.61 167.63 15.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -153.32 -74.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.88 119.33 32.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.33 37.49 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.764 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.24 26.16 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.392 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -54.0 58.64 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.619 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -88.12 99.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.844 2.363 . . . . 0.0 112.085 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' CD ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -49.44 125.55 11.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' O ' ' CG2' ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.134 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.899 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.73 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.783 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.134 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.783 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.899 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 m -110.21 -32.24 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 51.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.77 120.01 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.98 102.07 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tp 61.23 -168.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -142.58 -49.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.025 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -178.79 106.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.06 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -100.44 -9.0 0.12 Allowed Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 73.8 Cg_endo -77.79 -48.09 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.413 1.409 . . . . 0.0 112.537 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -176.75 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.221 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.568 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.119 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.656 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.779 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.755 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.811 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 32' ' ' MET . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.821 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.447 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 56' ' ' SER . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -153.71 73.34 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 115.51 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 -60.64 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.7 -172.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.732 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.82 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.213 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -104.64 71.23 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' PRO . . . 179.25 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.266 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.58 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 4.6 mt 15.39 -79.81 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 65.7 Cg_endo -75.97 -54.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.77 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.166 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 HD23 ' HG ' ' A' ' 39' ' ' LEU . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.78 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.166 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.809 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' CD2' ' SG ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.428 ' CG2' HG21 ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -72.31 -11.63 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.397 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 p -53.26 -71.34 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.767 0.318 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 96.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.756 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -29.27 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.26 60.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.46 64.14 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.32 79.75 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.027 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.01 156.41 74.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.53 108.4 2.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.484 2.123 . . . . 0.0 112.192 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.42 -59.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.596 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.143 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.489 HG23 ' HA ' ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.803 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.803 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.725 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.805 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.143 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.596 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' MET . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.814 0.34 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -62.51 -31.5 72.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.9 p -65.18 -71.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.13 129.69 40.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -60.34 -37.47 80.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.1 mt -101.34 -177.28 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -134.71 -52.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.98 65.1 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.642 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 20.7 mt 57.89 164.35 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.047 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 3.3 Cg_endo -46.01 -72.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.952 2.435 . . . . 0.0 112.639 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 174.79 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.098 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' CD1' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.02 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.799 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 1.02 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.666 ' HB ' ' HA ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.882 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.098 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.882 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.612 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.799 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.338 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -98.87 32.53 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.52 -28.86 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -177.67 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -119.82 -79.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.774 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 6.3 mt -136.63 -101.11 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.1 p30 164.86 37.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.445 0.164 . . . . 0.0 111.214 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 172.5 176.13 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 111.629 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -101.41 165.56 13.88 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 10' ' ' LEU . 3.3 Cg_exo -36.71 116.04 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.293 2.662 . . . . 0.0 112.573 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 51.57 175.18 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.96 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' CG2' HG13 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 16' ' ' PRO . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.139 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 23' ' ' LEU . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.757 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.759 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.879 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.139 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.658 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.82 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.879 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.759 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -125.56 67.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m -143.16 28.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.82 -38.9 15.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.95 159.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.88 148.63 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -73.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.92 139.45 35.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.78 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.6 mt 179.14 -63.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.744 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 61.0 Cg_endo -87.91 -31.62 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.59 2.193 . . . . 0.0 112.97 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.48 97.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.556 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.601 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.133 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' MET . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.797 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.853 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.133 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.758 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.617 ' CD1' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 32' ' ' MET . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 40' ' ' VAL . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.42 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.75 0.309 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -98.56 28.86 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -33.38 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 m -100.77 -174.58 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.824 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -105.28 -82.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -161.12 -95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 161.86 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.714 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' LEU . . . 56.76 164.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.557 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.1 tt 164.46 -52.8 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -68.63 66.52 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.31 2.007 . . . . 0.0 112.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 2.1 mpt_? 62.74 116.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.243 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.421 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.538 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.049 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.588 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 22' ' ' ILE . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.616 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.798 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.785 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.049 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 32' ' ' MET . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.485 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.881 0.372 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.7 p -58.47 -52.44 65.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -171.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -41.65 3.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.33 151.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.83 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.371 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 125.08 25.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.683 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 8.7 mt -101.14 -52.58 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.627 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 83.3 Cg_endo -92.97 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.625 2.217 . . . . 0.0 112.778 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.31 148.72 0.37 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.627 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.15 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' O ' ' CG2' ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.682 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.547 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.961 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.595 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.822 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.15 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.793 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.822 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.762 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.835 0.35 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 m -70.09 -22.64 63.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -54.36 -29.24 47.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 t -92.22 90.53 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -69.97 -76.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.808 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.98 97.86 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -89.84 53.32 2.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.87 166.0 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 111.435 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -80.46 168.21 27.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 4.6 Cg_exo -39.56 -32.72 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.943 2.428 . . . . 0.0 112.465 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.5 133.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.529 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.016 ' CD2' ' HB2' ' A' ' 36' ' ' GLU 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.716 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.683 ' O ' ' C ' ' A' ' 23' ' ' LEU . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.996 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.886 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.996 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.942 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.016 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.942 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ILE 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.886 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.853 0.359 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -62.37 -71.31 0.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -77.01 92.39 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -172.44 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 5' ' ' SER . 2.7 ttt85 79.24 15.31 1.0 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.0 tp 46.63 74.98 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.27 -169.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.66 -92.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.686 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.627 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -152.16 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.836 -0.165 . . . . 0.0 111.141 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 66.3 Cg_endo -89.1 -168.35 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.351 2.034 . . . . 0.0 112.417 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.7 125.61 27.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.387 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.666 ' O ' ' CG2' ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.666 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.679 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.097 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.68 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.78 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.849 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.849 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.78 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.518 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.823 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.097 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.823 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.679 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 32' ' ' MET . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' O ' ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.905 0.383 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -98.76 30.94 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.0 p -119.57 30.49 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.78 -171.77 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -142.62 -79.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.4 -84.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 172.18 -50.05 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.72 124.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mt -74.08 -48.93 5.88 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.587 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 74.0 Cg_endo -75.45 158.39 40.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.314 2.009 . . . . 0.0 112.437 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 18.18 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.466 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.694 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.694 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.672 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 15' ' ' CYS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.114 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.692 HG23 ' HA ' ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.593 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.731 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.805 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.764 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.839 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.114 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 39' ' ' LEU . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -108.87 -30.42 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -58.97 -45.22 91.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 80.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 62.77 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.207 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -90.76 101.72 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.77 130.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.632 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 4.3 mp -53.2 -50.73 80.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.359 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 89.1 Cg_endo -93.47 -93.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.923 2.415 . . . . 0.0 112.461 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? -135.47 -88.8 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.602 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.129 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.626 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 HD12 ' SG ' ' A' ' 15' ' ' CYS . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' O ' ' N ' ' A' ' 38' ' ' GLY . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.129 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.825 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.602 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 40' ' ' VAL . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.747 0.308 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 -32.25 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 p -109.25 -31.57 7.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 154.91 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -144.2 -75.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mt -172.81 152.64 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.23 83.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.35 72.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -60.94 -62.94 4.96 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 85.7 Cg_endo -79.16 -169.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.55 2.167 . . . . 0.0 112.156 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.24 122.0 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' ILE . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.6 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.123 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.594 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.6 ' HA ' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.999 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.812 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.999 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.838 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.123 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.838 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.675 ' O ' HG21 ' A' ' 40' ' ' VAL . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' H ' HG21 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.807 0.337 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -82.83 103.67 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 p -141.93 -48.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.48 115.7 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -110.24 -74.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 161.09 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -139.0 66.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.95 58.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -67.88 -59.62 6.36 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.0 Cg_endo -84.96 -167.4 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.722 2.282 . . . . 0.0 112.162 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 -77.51 -170.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.402 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.565 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.165 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' CB ' ' A' ' 34' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.764 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 1.015 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.663 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.826 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.165 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.015 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -88.11 -26.38 22.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -94.13 44.64 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.07 147.37 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -79.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -115.93 -9.21 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.378 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER 87.39 -23.2 0.13 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.779 0.432 . . . . 0.0 111.575 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.48 145.44 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.249 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -77.8 -52.51 1.62 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 96.6 Cg_endo -80.65 -166.79 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.583 2.189 . . . . 0.0 112.399 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.38 130.89 52.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.566 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.122 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.639 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.62 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.62 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.831 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.122 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.441 ' SG ' HD22 ' A' ' 39' ' ' LEU . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.831 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.611 HD13 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' MET . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.611 HG22 HD13 ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.817 0.342 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -81.32 -30.71 33.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -71.68 -76.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.71 170.5 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 -52.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.84 145.49 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.95 43.88 2.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.697 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.73 135.96 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . 3.4 tm? -178.54 -55.97 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.844 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 56.7 Cg_endo -71.89 -88.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.005 1.803 . . . . 0.0 112.474 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -147.48 -81.39 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.794 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.092 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.578 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.741 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.578 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.739 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.907 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.816 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.092 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.794 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.907 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG2' ' C ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.832 0.349 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -137.74 27.44 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.9 p -158.26 30.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.29 118.36 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.2 -71.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.67 -165.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.65 -45.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.227 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -90.44 -43.72 10.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.362 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 164.73 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.017 -179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 10' ' ' LEU . 19.4 Cg_endo -58.41 96.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.373 2.049 . . . . 0.0 112.242 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.66 115.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.408 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.65 HG21 HG23 ' A' ' 22' ' ' ILE . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.629 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.149 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 HG21 ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.545 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.7 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.775 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.877 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.786 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.149 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.629 HD22 ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -75.74 -42.76 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.79 60.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.82 170.9 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -165.03 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.12 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.14 72.16 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -54.09 163.47 0.78 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 10' ' ' LEU . . . 54.34 52.06 13.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.417 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tp -15.65 -66.35 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.396 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 36.8 Cg_endo -69.46 -77.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.047 1.831 . . . . 0.0 112.198 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 178.81 0.38 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.494 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.567 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.111 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.696 ' CB ' ' HD2' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD23 ' HG ' ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.804 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.592 HD12 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.857 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.111 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.778 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.857 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.804 ' HA ' ' O ' ' A' ' 32' ' ' MET . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 40' ' ' VAL . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.32 -61.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -64.92 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.55 -165.56 0.21 Allowed 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -175.72 169.76 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.4 tp -52.54 95.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 -157.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.285 -179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.27 -77.13 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.08 60.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.52 150.69 17.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.315 . . . . 0.0 112.421 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.44 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.603 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.118 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 33' ' ' ILE . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.844 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.864 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.768 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.118 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.844 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD22 ' CB ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' A' ' 32' ' ' MET . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -93.29 -35.63 12.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 p -67.99 -31.46 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -128.63 154.22 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -100.06 -32.54 10.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.25 142.83 50.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.82 -43.45 2.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.87 153.69 27.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.12 -50.28 1.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.917 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 90.5 Cg_endo -83.46 -164.35 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.579 2.186 . . . . 0.0 111.927 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.545 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -99.08 31.49 3.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.604 ' SG ' HD22 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.401 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 1.089 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.672 ' HB2' ' HD2' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 32' ' ' MET . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' TYR . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' TYR . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.768 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.883 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 1.089 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.883 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.604 HD22 ' SG ' ' A' ' 15' ' ' CYS . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 32' ' ' MET . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 40' ' ' VAL . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.537 HG12 ' N ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.537 ' N ' HG12 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.692 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.452 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 14' ' ' THR . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 HG22 ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' HD23 ' A' ' 23' ' ' LEU . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.015 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.452 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 31' ' ' ASP . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.845 HG23 HD11 ' A' ' 39' ' ' LEU . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 54' ' ' THR . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 13' ' ' VAL . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.557 ' CG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.618 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.53 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.465 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' CG2' ' A' ' 14' ' ' THR . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.973 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.465 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.101 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.649 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.136 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.136 ' O ' HD12 ' A' ' 39' ' ' LEU . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.785 ' O ' HD13 ' A' ' 46' ' ' ILE . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 45' ' ' VAL . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' HG22 ' A' ' 54' ' ' THR . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 14' ' ' THR . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.757 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.744 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.521 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.92 HD13 ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.623 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 1.018 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.01 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.521 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' HG23 ' A' ' 24' ' ' VAL . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.233 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.425 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.01 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.018 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.881 HG23 ' CD1' ' A' ' 39' ' ' LEU . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG12 ' A' ' 45' ' ' VAL . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 54' ' ' THR . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.522 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.361 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.594 ' HB2' HG21 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 23' ' ' LEU . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.361 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.294 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 39' ' ' LEU . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.788 HG23 HD11 ' A' ' 39' ' ' LEU . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' OD2' ' A' ' 47' ' ' ASP . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.523 HG23 ' N ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.645 ' OD2' HG13 ' A' ' 45' ' ' VAL . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 53' ' ' ARG . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 51' ' ' GLU . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.494 ' H ' HG22 ' A' ' 54' ' ' THR . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.909 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.348 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.909 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.893 HG12 ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.893 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.912 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.348 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.246 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.769 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.912 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' ILE . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 54' ' ' THR . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.719 0.295 . . . . 0.0 111.221 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.758 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.392 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 22' ' ' ILE . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 HG23 ' A' ' 41' ' ' VAL . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.67 ' HB2' ' CB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.785 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.797 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.392 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.207 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.708 HD11 ' CG2' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.836 HG12 ' OD2' ' A' ' 31' ' ' ASP . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.834 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 47' ' ' ASP . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 46' ' ' ILE . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.706 0.288 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.404 HG13 ' OG1' ' A' ' 14' ' ' THR . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.645 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.603 ' SG ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.532 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.348 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' O ' HG21 ' A' ' 14' ' ' THR . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.773 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 41' ' ' VAL . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.895 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.348 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.288 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.775 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.754 HD11 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.895 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.641 HG23 ' CG2' ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.641 ' CG2' HG23 ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.485 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.961 HG22 ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.599 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.72 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.464 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HG22 ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.818 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.769 ' O ' HD23 ' A' ' 23' ' ' LEU . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.464 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.139 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.797 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 39' ' ' LEU . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.853 HG23 HD11 ' A' ' 39' ' ' LEU . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 46' ' ' ILE . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.706 HG23 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.595 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.664 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.416 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.706 ' CD1' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD22 HG23 ' A' ' 41' ' ' VAL . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.053 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.798 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 1.053 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.909 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.416 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.143 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.611 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.909 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.9 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 46' ' ' ILE . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 54' ' ' THR . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.579 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.594 ' HB3' ' HD1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.159 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.731 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.801 ' HA ' HG22 ' A' ' 14' ' ' THR . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD11 HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.836 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.159 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.782 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.881 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.556 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.849 HG23 HG23 ' A' ' 48' ' ' VAL . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 46' ' ' ILE . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' H ' HG22 ' A' ' 54' ' ' THR . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.889 0.376 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.305 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' GLU . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 29' ' ' ALA . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.305 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.267 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.61 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.008 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 39' ' ' LEU . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG23 HD11 ' A' ' 39' ' ' LEU . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 54' ' ' THR . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 2.1 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.333 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.642 HG23 HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.451 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.642 HG23 HG23 ' A' ' 14' ' ' THR . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.705 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.83 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.819 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.451 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.697 HG12 ' OD2' ' A' ' 31' ' ' ASP . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.579 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 49' ' ' GLY . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 48' ' ' VAL . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 13' ' ' VAL . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.733 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.636 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.31 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' HG21 ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.785 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.971 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.287 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.31 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.971 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.834 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.402 ' N ' HG13 ' A' ' 45' ' ' VAL . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.605 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.894 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.428 ' CE1' ' SG ' ' A' ' 34' ' ' CYS 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 14' ' ' THR . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 24' ' ' VAL . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.02 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.902 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.428 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.931 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.655 ' SG ' HD23 ' A' ' 39' ' ' LEU . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.92 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 41' ' ' VAL 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.902 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.769 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.785 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.458 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.86 HG12 HG22 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' HD3' ' A' ' 35' ' ' PRO . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.829 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.848 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASP . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.829 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.458 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HD3' HG23 ' A' ' 24' ' ' VAL . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.034 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 39' ' ' LEU . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' C ' HG12 ' A' ' 45' ' ' VAL . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.649 HG22 ' N ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.649 ' N ' HG22 ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 51' ' ' GLU . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' HG21 ' A' ' 48' ' ' VAL . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 54' ' ' THR . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.031 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.732 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.484 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.637 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.874 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.752 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.869 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.484 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.265 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' HD23 ' A' ' 39' ' ' LEU . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.076 HD11 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.82 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.076 HG23 HD11 ' A' ' 39' ' ' LEU . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.555 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.668 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.317 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 39' ' ' LEU . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 27' ' ' TYR . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.791 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.317 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.298 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 39' ' ' LEU . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 45' ' ' VAL . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 14' ' ' THR . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.757 HG23 ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.593 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.719 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.409 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.757 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 39' ' ' LEU . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.044 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.409 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.178 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.416 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.828 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 23' ' ' LEU . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.827 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 12' ' ' ARG . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.531 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' O ' HG21 ' A' ' 14' ' ' THR . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' SG ' ' A' ' 15' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.795 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.619 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 1.057 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.531 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.03 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.51 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.057 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 39' ' ' LEU . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 47' ' ' ASP . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HE ' HG11 ' A' ' 41' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.623 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.456 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.484 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.659 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 27' ' ' TYR . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.774 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.484 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.111 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.825 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.8 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 31' ' ' ASP . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.433 HD13 ' C ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' H ' HG22 ' A' ' 54' ' ' THR . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.861 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.711 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.608 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.484 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 14' ' ' THR . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.759 HD13 ' NH1' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 40' ' ' VAL . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.597 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.928 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.484 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.128 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.509 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.78 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 49' ' ' GLY . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.734 0.302 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.687 ' N ' HG13 ' A' ' 13' ' ' VAL . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.503 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.673 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.833 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.503 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.117 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.573 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.666 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' THR . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.519 HG22 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.567 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.323 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD13 HG22 ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.729 ' OD1' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.832 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.59 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.292 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.323 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.714 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.858 ' O ' HD12 ' A' ' 39' ' ' LEU . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG23 HD22 ' A' ' 23' ' ' LEU . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 46' ' ' ILE . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.482 ' C ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.608 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.448 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 32' ' ' MET . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.86 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.731 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.866 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.852 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.448 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.137 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.866 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG23 HD11 ' A' ' 39' ' ' LEU . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 41' ' ' VAL . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.663 0.268 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 14' ' ' THR . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.653 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.787 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 1.406 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.635 ' O ' HG21 ' A' ' 14' ' ' THR . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD21 HD11 ' A' ' 39' ' ' LEU . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.799 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 1.406 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 1.214 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.842 ' O ' HD12 ' A' ' 39' ' ' LEU . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 39' ' ' LEU . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.401 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.401 HG23 ' HE3' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -88.07 54.66 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.8 p -120.8 34.82 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.36 -170.42 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.83 ' HD3' HG21 ' A' ' 46' ' ' ILE . 12.8 mtt85 -108.15 -74.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tp -108.98 126.74 53.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -153.78 48.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.28 -55.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.38 64.54 3.56 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.449 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.06 66.98 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.783 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.16 -151.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.692 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.452 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 14' ' ' THR . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 HG22 ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' HD23 ' A' ' 23' ' ' LEU . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.452 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 31' ' ' ASP . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.845 HG23 HD11 ' A' ' 39' ' ' LEU . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.83 HG21 ' HD3' ' A' ' 6' ' ' ARG . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 54' ' ' THR . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.908 0.385 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -123.82 2.06 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.397 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 p -125.09 3.51 7.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.386 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.55 156.82 19.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.15 -65.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -164.89 48.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.81 -72.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -132.2 130.99 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -80.61 -50.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 94.2 Cg_endo -81.1 160.56 20.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.428 2.085 . . . . 0.0 112.418 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -177.98 4.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 13' ' ' VAL . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.557 ' CG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.618 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.155 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' CG2' ' A' ' 14' ' ' THR . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.973 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.789 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.155 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.649 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.136 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.136 ' O ' HD12 ' A' ' 39' ' ' LEU . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.785 ' O ' HD13 ' A' ' 46' ' ' ILE . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 45' ' ' VAL . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' HG22 ' A' ' 54' ' ' THR . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.331 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -113.59 47.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -150.81 75.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 t -162.74 153.65 17.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.726 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -114.15 -70.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 173.22 40.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 77.2 -54.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.84 164.51 36.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.177 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -111.02 -55.29 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.594 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 48.9 Cg_endo -87.92 -80.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.433 2.089 . . . . 0.0 112.922 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 170.41 21.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 14' ' ' THR . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.757 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.744 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.233 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.92 HD13 ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.623 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 1.018 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.01 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.885 ' O ' ' N ' ' A' ' 38' ' ' GLY . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' HG23 ' A' ' 24' ' ' VAL . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.233 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.425 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.01 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.018 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.881 HG23 ' CD1' ' A' ' 39' ' ' LEU . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG12 ' A' ' 45' ' ' VAL . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 54' ' ' THR . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.92 0.391 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.97 -32.27 14.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 p -85.82 -29.57 23.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.489 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 34.6 t -58.38 134.4 56.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -69.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -177.3 125.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.44 128.09 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.78 177.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.978 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -88.91 -51.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD3' HD12 ' A' ' 10' ' ' LEU . 97.5 Cg_endo -87.64 -166.41 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.669 2.246 . . . . 0.0 112.379 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -125.49 -90.79 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.63 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.522 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.294 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.594 ' HB2' HG21 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 23' ' ' LEU . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.804 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.294 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 39' ' ' LEU . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.788 HG23 HD11 ' A' ' 39' ' ' LEU . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' OD2' ' A' ' 47' ' ' ASP . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.523 HG23 ' N ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' OD2' HG13 ' A' ' 45' ' ' VAL . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 53' ' ' ARG . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 51' ' ' GLU . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.494 ' H ' HG22 ' A' ' 54' ' ' THR . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -95.02 18.79 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.89 28.64 7.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 110.803 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.61 167.63 15.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -153.32 -74.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.88 119.33 32.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.33 37.49 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.764 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.24 26.16 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.392 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -54.0 58.64 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.619 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -88.12 99.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.844 2.363 . . . . 0.0 112.085 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -49.44 125.55 11.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.909 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.246 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.909 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.893 HG12 ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.893 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.912 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' N ' HD13 ' A' ' 33' ' ' ILE . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.246 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.769 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.912 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' ILE . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 54' ' ' THR . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 m -110.21 -32.24 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 51.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.77 120.01 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.98 102.07 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 7' ' ' LEU . 3.7 tp 61.23 -168.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -142.58 -49.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.025 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -178.79 106.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -100.44 -9.0 0.12 Allowed Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 73.8 Cg_endo -77.79 -48.09 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.413 1.409 . . . . 0.0 112.537 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -176.75 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.221 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.758 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.207 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 22' ' ' ILE . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 HG23 ' A' ' 41' ' ' VAL . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.67 ' HB2' ' CB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.785 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.797 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.804 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.207 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.708 HD11 ' CG2' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.836 HG12 ' OD2' ' A' ' 31' ' ' ASP . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.834 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 47' ' ' ASP . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 46' ' ' ILE . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -153.71 73.34 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 115.51 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 -60.64 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.7 -172.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.732 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.787 HD22 ' HG ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -45.82 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.213 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 5.3 p30 -104.64 71.23 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' PRO . . . 179.25 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.266 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.787 ' HG ' HD22 ' A' ' 7' ' ' LEU . 4.6 mt 15.39 -79.81 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 65.7 Cg_endo -75.97 -54.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 168.77 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.404 HG13 ' OG1' ' A' ' 14' ' ' THR . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.645 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.603 ' SG ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.532 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.288 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' O ' HG21 ' A' ' 14' ' ' THR . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.773 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 41' ' ' VAL . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.895 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.775 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.288 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.775 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.754 HD11 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.895 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.641 HG23 ' CG2' ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.641 ' CG2' HG23 ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -72.31 -11.63 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.397 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 p -53.26 -71.34 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.767 0.318 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 96.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.756 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -29.27 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -111.26 60.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.46 64.14 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.32 79.75 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.027 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.01 156.41 74.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.53 108.4 2.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.484 2.123 . . . . 0.0 112.192 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.42 -59.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.961 HG22 ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.72 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.139 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HG22 ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.818 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.769 ' O ' HD23 ' A' ' 23' ' ' LEU . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.797 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.139 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.797 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 39' ' ' LEU . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.853 HG23 HD11 ' A' ' 39' ' ' LEU . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 7' ' ' LEU . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.814 0.34 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -62.51 -31.5 72.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.9 p -65.18 -71.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.13 129.69 40.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -60.34 -37.47 80.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 7' ' ' LEU . 21.1 mt -101.34 -177.28 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -134.71 -52.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.98 65.1 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.642 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 20.7 mt 57.89 164.35 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.047 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 3.3 Cg_endo -46.01 -72.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.952 2.435 . . . . 0.0 112.639 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 174.79 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.706 HG23 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.119 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.886 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.706 ' CD1' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD22 HG23 ' A' ' 41' ' ' VAL . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.053 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.798 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 1.053 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.909 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.611 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.909 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.9 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 46' ' ' ILE . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 54' ' ' THR . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.338 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -98.87 32.53 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.52 -28.86 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -177.67 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -119.82 -79.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.774 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 6.3 mt -136.63 -101.11 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 4.1 p30 164.86 37.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.445 0.164 . . . . 0.0 111.214 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 8' ' ' ASP . . . 172.5 176.13 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 111.629 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -101.41 165.56 13.88 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 10' ' ' LEU . 3.3 Cg_exo -36.71 116.04 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.293 2.662 . . . . 0.0 112.573 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 51.57 175.18 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.96 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.579 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.594 ' HB3' ' HD1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.159 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.731 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.801 ' HA ' HG22 ' A' ' 14' ' ' THR . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD11 HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.836 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.159 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.707 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.881 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.556 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.849 HG23 HG23 ' A' ' 48' ' ' VAL . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 46' ' ' ILE . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' H ' HG22 ' A' ' 54' ' ' THR . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -125.56 67.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.567 ' O ' HG22 ' A' ' 4' ' ' THR . 27.7 m -143.16 28.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.82 -38.9 15.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.95 159.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.88 148.63 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -73.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.92 139.45 35.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.78 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.6 mt 179.14 -63.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.744 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 61.0 Cg_endo -87.91 -31.62 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.59 2.193 . . . . 0.0 112.97 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.48 97.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.556 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.267 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' GLU . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 29' ' ' ALA . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.826 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.267 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.61 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.008 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 39' ' ' LEU . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG23 HD11 ' A' ' 39' ' ' LEU . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 54' ' ' THR . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.75 0.309 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -98.56 28.86 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -33.38 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 m -100.77 -174.58 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.824 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.71 ' O ' HD12 ' A' ' 7' ' ' LEU . 6.4 mtp85 -105.28 -82.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -161.12 -95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 161.86 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.714 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' LEU . . . 56.76 164.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.557 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.1 tt 164.46 -52.8 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -68.63 66.52 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.31 2.007 . . . . 0.0 112.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 2.1 mpt_? 62.74 116.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.243 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.642 HG23 HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.687 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.119 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.61 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG23 HG23 ' A' ' 14' ' ' THR . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.705 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.83 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.819 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.785 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.697 HG12 ' OD2' ' A' ' 31' ' ' ASP . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 49' ' ' GLY . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 48' ' ' VAL . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.881 0.372 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.7 p -58.47 -52.44 65.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -171.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -41.65 3.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.33 151.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.83 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.371 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 125.08 25.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 8.7 mt -101.14 -52.58 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.627 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.692 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 83.3 Cg_endo -92.97 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.625 2.217 . . . . 0.0 112.778 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.31 148.72 0.37 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 13' ' ' VAL . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.733 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.31 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' HG21 ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.785 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.971 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.801 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.31 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.971 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.834 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' N ' HG13 ' A' ' 45' ' ' VAL . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.835 0.35 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 m -70.09 -22.64 63.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -54.36 -29.24 47.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 t -92.22 90.53 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -69.97 -76.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.808 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.98 97.86 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -89.84 53.32 2.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.87 166.0 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 111.435 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -80.46 168.21 27.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 4.6 Cg_exo -39.56 -32.72 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.943 2.428 . . . . 0.0 112.465 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.5 133.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.894 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.931 ' CE1' ' HB2' ' A' ' 36' ' ' GLU 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 14' ' ' THR . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 24' ' ' VAL . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.02 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.902 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.92 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.931 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.655 ' SG ' HD23 ' A' ' 39' ' ' LEU . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.92 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 41' ' ' VAL 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.902 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.853 0.359 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -62.37 -71.31 0.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -77.01 92.39 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -172.44 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 5' ' ' SER . 2.7 ttt85 79.24 15.31 1.0 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.0 tp 46.63 74.98 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.27 -169.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -68.66 -92.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.633 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -152.16 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.836 -0.165 . . . . 0.0 111.141 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 66.3 Cg_endo -89.1 -168.35 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.351 2.034 . . . . 0.0 112.417 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.7 125.61 27.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.387 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.769 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.487 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.114 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.86 HG12 HG22 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' HD3' ' A' ' 35' ' ' PRO . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.829 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.848 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASP . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.829 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HD3' HG23 ' A' ' 24' ' ' VAL . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.114 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 39' ' ' LEU . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' C ' HG12 ' A' ' 45' ' ' VAL . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.649 HG22 ' N ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.649 ' N ' HG22 ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 51' ' ' GLU . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' HG21 ' A' ' 48' ' ' VAL . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 54' ' ' THR . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.905 0.383 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -98.76 30.94 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.0 p -119.57 30.49 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.78 -171.77 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -142.62 -79.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.4 -84.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 172.18 -50.05 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.72 124.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mt -74.08 -48.93 5.88 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.587 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 74.0 Cg_endo -75.45 158.39 40.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.314 2.009 . . . . 0.0 112.437 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 18.18 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.466 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.031 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.732 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.265 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.637 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.874 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.752 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.869 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.839 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.265 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' HD23 ' A' ' 39' ' ' LEU . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.076 HD11 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.82 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.076 HG23 HD11 ' A' ' 39' ' ' LEU . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -108.87 -30.42 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -58.97 -45.22 91.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 80.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 62.77 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.207 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 39.4 p-10 -90.76 101.72 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.77 130.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.632 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 4.3 mp -53.2 -50.73 80.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.359 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 89.1 Cg_endo -93.47 -93.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.923 2.415 . . . . 0.0 112.461 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.555 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? -135.47 -88.8 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.547 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.668 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.298 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 39' ' ' LEU . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 27' ' ' TYR . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.791 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' O ' ' N ' ' A' ' 38' ' ' GLY . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.298 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 39' ' ' LEU . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 45' ' ' VAL . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.747 0.308 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 -32.25 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 p -109.25 -31.57 7.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 154.91 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -144.2 -75.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mt -172.81 152.64 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.23 83.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.35 72.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -60.94 -62.94 4.96 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 85.7 Cg_endo -79.16 -169.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.55 2.167 . . . . 0.0 112.156 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -92.24 122.0 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 14' ' ' THR . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.757 HG23 ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.719 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.178 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.757 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 39' ' ' LEU . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.044 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.828 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.178 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.416 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.828 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 23' ' ' LEU . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.827 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 12' ' ' ARG . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.807 0.337 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -82.83 103.67 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 p -141.93 -48.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.48 115.7 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -110.24 -74.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 161.09 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -139.0 66.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.95 58.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -67.88 -59.62 6.36 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.0 Cg_endo -84.96 -167.4 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.722 2.282 . . . . 0.0 112.162 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 -77.51 -170.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.402 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.03 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' O ' HG21 ' A' ' 14' ' ' THR . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' SG ' ' A' ' 15' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.795 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.619 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 1.057 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.826 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.03 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.51 ' SG ' HD23 ' A' ' 39' ' ' LEU . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.057 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 39' ' ' LEU . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 47' ' ' ASP . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -88.11 -26.38 22.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -94.13 44.64 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.07 147.37 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -79.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -115.93 -9.21 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.378 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER 87.39 -23.2 0.13 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.779 0.432 . . . . 0.0 111.575 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.48 145.44 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.249 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -77.8 -52.51 1.62 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 96.6 Cg_endo -80.65 -166.79 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.583 2.189 . . . . 0.0 112.399 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HE ' HG11 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -125.38 130.89 52.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.009 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.456 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.111 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.659 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 27' ' ' TYR . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.774 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.825 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.111 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.825 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.8 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 31' ' ' ASP . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.433 HD13 ' C ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' H ' HG22 ' A' ' 54' ' ' THR . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.817 0.342 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -81.32 -30.71 33.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -71.68 -76.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.71 170.5 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 -52.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.84 145.49 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.95 43.88 2.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.697 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.73 135.96 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . 3.4 tm? -178.54 -55.97 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.844 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 56.7 Cg_endo -71.89 -88.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.005 1.803 . . . . 0.0 112.474 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.861 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -147.48 -81.39 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.711 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.608 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.128 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 14' ' ' THR . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.759 HD13 ' NH1' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 40' ' ' VAL . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.597 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.928 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.816 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.128 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.78 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 49' ' ' GLY . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.832 0.349 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 4' ' ' THR . 4.7 m -137.74 27.44 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 3' ' ' SER . 39.9 p -158.26 30.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.29 118.36 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.2 -71.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.67 -165.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.65 -45.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.227 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 10' ' ' LEU . . . -90.44 -43.72 10.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.362 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER 164.73 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.017 -179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 10' ' ' LEU . 19.4 Cg_endo -58.41 96.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.373 2.049 . . . . 0.0 112.242 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.66 115.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.408 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.687 ' N ' HG13 ' A' ' 13' ' ' VAL . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.117 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.673 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.833 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.786 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.117 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.573 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.666 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -75.74 -42.76 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.79 60.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.82 170.9 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -165.03 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.12 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.14 72.16 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -54.09 163.47 0.78 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 10' ' ' LEU . . . 54.34 52.06 13.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.417 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tp -15.65 -66.35 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.396 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 36.8 Cg_endo -69.46 -77.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.047 1.831 . . . . 0.0 112.198 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 178.81 0.38 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.494 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' THR . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.519 HG22 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.567 ' C ' ' HD2' ' A' ' 18' ' ' HIS . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.323 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD13 HG22 ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.729 ' OD1' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.832 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.59 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.825 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.323 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.714 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.858 ' O ' HD12 ' A' ' 39' ' ' LEU . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG23 HD22 ' A' ' 23' ' ' LEU . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 46' ' ' ILE . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.32 -61.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -64.92 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.55 -165.56 0.21 Allowed 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -175.72 169.76 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.4 tp -52.54 95.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 -157.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.285 -179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -45.27 -77.13 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.08 60.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.52 150.69 17.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.315 . . . . 0.0 112.421 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.44 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.482 ' C ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.137 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 32' ' ' MET . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.86 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.731 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.866 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.852 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.852 ' N ' HD13 ' A' ' 33' ' ' ILE . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.137 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.866 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG23 HD11 ' A' ' 39' ' ' LEU . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 41' ' ' VAL . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -93.29 -35.63 12.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 p -67.99 -31.46 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -128.63 154.22 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -100.06 -32.54 10.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.25 142.83 50.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.82 -43.45 2.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.87 153.69 27.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.12 -50.28 1.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.917 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 90.5 Cg_endo -83.46 -164.35 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.579 2.186 . . . . 0.0 111.927 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -99.08 31.49 3.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 14' ' ' THR . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.653 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.787 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 1.214 ' CE1' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.635 ' O ' HG21 ' A' ' 14' ' ' THR . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD21 HD11 ' A' ' 39' ' ' LEU . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.799 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.847 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 1.214 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.842 ' O ' HD12 ' A' ' 39' ' ' LEU . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 39' ' ' LEU . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.401 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.401 HG23 ' HE3' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.739 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.252 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 14' ' ' THR . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.903 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 HG22 ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' HD23 ' A' ' 23' ' ' LEU . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.252 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.811 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 31' ' ' ASP . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.845 HG23 HD11 ' A' ' 39' ' ' LEU . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 45' ' ' VAL . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 54' ' ' THR . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.557 ' CG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.795 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.271 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' CG2' ' A' ' 14' ' ' THR . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.973 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.271 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.155 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.825 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.136 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.136 ' O ' HD12 ' A' ' 39' ' ' LEU . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.785 ' O ' HD13 ' A' ' 46' ' ' ILE . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 45' ' ' VAL . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' HG22 ' A' ' 54' ' ' THR . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 14' ' ' THR . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.319 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.92 HD13 ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.623 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 1.018 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.01 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.319 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' HG23 ' A' ' 24' ' ' VAL . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.148 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.783 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.01 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.018 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.881 HG23 ' CD1' ' A' ' 39' ' ' LEU . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG12 ' A' ' 45' ' ' VAL . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 54' ' ' THR . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.785 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.196 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.027 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.594 ' HB2' HG21 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 23' ' ' LEU . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.167 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.196 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.845 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 39' ' ' LEU . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.788 HG23 HD11 ' A' ' 39' ' ' LEU . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' OD2' ' A' ' 47' ' ' ASP . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.523 HG23 ' N ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.645 ' OD2' HG13 ' A' ' 45' ' ' VAL . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 53' ' ' ARG . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 51' ' ' GLU . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.494 ' H ' HG22 ' A' ' 54' ' ' THR . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.909 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.18 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.909 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.893 HG12 ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.893 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.912 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.16 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.18 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.864 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.769 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.912 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 46' ' ' ILE . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 54' ' ' THR . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.719 0.295 . . . . 0.0 111.221 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.795 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.192 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.025 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 22' ' ' ILE . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 HG23 ' A' ' 41' ' ' VAL . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.67 ' HB2' ' CB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.785 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.797 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.192 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.142 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.842 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.708 HD11 ' CG2' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.836 HG12 ' OD2' ' A' ' 31' ' ' ASP . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.834 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 47' ' ' ASP . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 46' ' ' ILE . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.706 0.288 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.404 HG13 ' OG1' ' A' ' 14' ' ' THR . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.645 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.199 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' O ' HG21 ' A' ' 14' ' ' THR . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 41' ' ' VAL . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.895 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.148 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.199 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.849 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.775 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.754 HD11 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.895 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.641 HG23 ' CG2' ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.641 ' CG2' HG23 ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.485 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.961 HG22 ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.797 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.253 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HG22 ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.818 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.769 ' O ' HD23 ' A' ' 23' ' ' LEU . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.253 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.168 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.826 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.797 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 39' ' ' LEU . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.853 HG23 HD11 ' A' ' 39' ' ' LEU . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 46' ' ' ILE . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.706 HG23 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.8 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.23 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.886 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.706 ' CD1' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD22 HG23 ' A' ' 41' ' ' VAL . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.053 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.798 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 1.053 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.909 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.23 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.845 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.909 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.9 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 46' ' ' ILE . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 54' ' ' THR . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.579 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.594 ' HB3' ' HD1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.159 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.731 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.801 ' HA ' HG22 ' A' ' 14' ' ' THR . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD11 HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.836 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.159 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.782 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.881 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.556 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.849 HG23 HG23 ' A' ' 48' ' ' VAL . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 46' ' ' ILE . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.484 ' H ' HG22 ' A' ' 54' ' ' THR . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.889 0.376 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.771 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.177 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' GLU . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 29' ' ' ALA . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.113 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.177 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.844 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.008 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 39' ' ' LEU . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG23 HD11 ' A' ' 39' ' ' LEU . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 54' ' ' THR . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 2.1 mpt_? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.333 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.642 HG23 HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.251 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.879 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.642 HG23 HG23 ' A' ' 14' ' ' THR . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.705 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.83 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.819 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.251 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.069 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.835 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.697 HG12 ' OD2' ' A' ' 31' ' ' ASP . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.579 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 46' ' ' ILE . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 49' ' ' GLY . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 48' ' ' VAL . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 13' ' ' VAL . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.733 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.786 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.182 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' HG21 ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.785 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.971 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.088 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.182 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.858 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.971 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.834 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.402 ' N ' HG13 ' A' ' 45' ' ' VAL . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.091 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.805 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.529 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.228 ' NE2' ' SG ' ' A' ' 34' ' ' CYS 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 14' ' ' THR . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 24' ' ' VAL . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.02 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.902 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.228 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.022 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.806 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.92 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 41' ' ' VAL 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.902 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.487 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.269 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.86 HG12 HG22 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' HD3' ' A' ' 35' ' ' PRO . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.829 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.848 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASP . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.829 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.269 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HD3' HG23 ' A' ' 24' ' ' VAL . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.114 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.837 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 39' ' ' LEU . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' C ' HG12 ' A' ' 45' ' ' VAL . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.649 HG22 ' N ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.649 ' N ' HG22 ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 51' ' ' GLU . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' HG21 ' A' ' 48' ' ' VAL . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 54' ' ' THR . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.031 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.814 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' CYS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.296 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.828 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.874 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.752 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.869 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.296 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.133 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.822 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.076 HD11 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.82 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.076 HG23 HD11 ' A' ' 39' ' ' LEU . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.555 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.162 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.889 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 39' ' ' LEU . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 27' ' ' TYR . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.791 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.114 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.162 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.859 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 39' ' ' LEU . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 45' ' ' VAL . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 14' ' ' THR . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.757 HG23 ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.793 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.209 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.944 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.757 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 39' ' ' LEU . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.044 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.209 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.136 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.842 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.828 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 23' ' ' LEU . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.827 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 12' ' ' ARG . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 48' ' ' VAL . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.33 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' O ' HG21 ' A' ' 14' ' ' THR . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.869 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' SG ' ' A' ' 15' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.795 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.619 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 1.057 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.33 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.207 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.816 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.057 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 39' ' ' LEU . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 47' ' ' ASP . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HE ' HG11 ' A' ' 41' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.815 0.341 . . . . 0.0 111.009 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.284 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.074 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.659 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 27' ' ' TYR . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.774 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.284 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.151 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.839 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.825 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.8 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 31' ' ' ASP . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.433 HD13 ' C ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' H ' HG22 ' A' ' 54' ' ' THR . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.861 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.802 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.276 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.983 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 14' ' ' THR . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.759 HD13 ' NH1' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 40' ' ' VAL . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.597 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.928 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.276 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.112 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.843 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.759 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.78 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 49' ' ' GLY . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.734 0.302 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.687 ' N ' HG13 ' A' ' 13' ' ' VAL . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.792 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.303 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.673 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.833 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.303 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.18 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.847 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.666 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.676 0.274 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' THR . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.519 HG22 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.786 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.123 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.929 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD13 HG22 ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.729 ' OD1' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.832 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.59 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.094 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.123 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.848 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.858 ' O ' HD12 ' A' ' 39' ' ' LEU . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG23 HD22 ' A' ' 23' ' ' LEU . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 46' ' ' ILE . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.482 ' C ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.423 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.248 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.849 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 32' ' ' MET . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.86 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.731 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.866 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.852 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.248 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.135 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.846 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.866 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG23 HD11 ' A' ' 39' ' ' LEU . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 41' ' ' VAL . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.663 0.268 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 14' ' ' THR . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.799 ' SG ' ' CE1' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 1.195 ' NE2' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.635 ' O ' HG21 ' A' ' 14' ' ' THR . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.996 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD21 HD11 ' A' ' 39' ' ' LEU . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.799 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 1.195 ' SG ' ' NE2' ' A' ' 18' ' ' HIS . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 1.113 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.847 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.842 ' O ' HD12 ' A' ' 39' ' ' LEU . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 39' ' ' LEU . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.401 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.401 HG23 ' HE3' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -88.07 54.66 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.8 p -120.8 34.82 5.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.36 -170.42 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.83 ' HD3' HG21 ' A' ' 46' ' ' ILE . 12.8 mtt85 -108.15 -74.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 tp -108.98 126.74 53.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -153.78 48.32 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.28 -55.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.371 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 58.38 64.54 3.56 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.449 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.06 66.98 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.783 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.16 -151.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 14' ' ' THR . 18.4 t -133.37 -65.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.775 0.321 . . . . 0.0 111.639 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER 169.29 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.447 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.692 ' SG ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -75.94 131.76 75.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' CD2' ' A' ' 39' ' ' LEU . 23.6 Cg_endo -60.78 -33.86 92.37 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.541 2.161 . . . . 0.0 110.34 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -85.27 -32.04 22.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.252 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -138.34 88.21 15.04 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.278 177.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.602 ' O ' HG21 ' A' ' 14' ' ' THR . 12.7 Cg_endo -56.35 -15.28 14.51 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.424 2.083 . . . . 0.0 110.822 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' ILE . 2.7 m-20 -81.96 -56.77 3.75 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.604 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.903 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -64.22 123.59 19.51 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 HG22 ' A' ' 14' ' ' THR . 4.1 mm -85.99 118.09 31.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.527 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 32' ' ' MET . 2.9 mp -55.79 138.03 48.76 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 32' ' ' MET . 46.3 t -93.64 151.73 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 O-C-N 121.495 -0.753 . . . . 0.0 111.363 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -70.4 136.57 49.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.183 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 27.0 t70 55.19 96.96 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -68.11 93.61 0.45 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.305 178.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 17.9 mmm-85 45.38 40.1 5.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.403 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 97.71 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.219 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -137.17 -131.48 2.96 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.949 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -98.05 -140.57 0.3 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.101 0.16 . . . . 0.0 111.234 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' HD23 ' A' ' 23' ' ' LEU . 49.7 mtp -90.25 110.49 21.54 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.415 0.626 . . . . 0.0 111.68 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.745 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -96.8 118.58 43.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' N ' ' A' ' 38' ' ' GLY . 8.8 t -80.43 106.77 5.71 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.164 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 3.2 Cg_endo -46.77 -17.17 0.35 Allowed 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.614 2.209 . . . . 0.0 115.022 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.252 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -101.46 -50.44 3.74 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.767 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 5.0 p -96.22 -13.35 23.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 64.17 22.34 66.97 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.376 -1.283 . . . . 0.0 113.647 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -65.63 144.3 57.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.638 -0.781 . . . . 0.0 111.547 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 31' ' ' ASP . 3.8 t -112.11 124.66 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.195 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.845 HG23 HD11 ' A' ' 39' ' ' LEU . 69.6 t -128.25 135.25 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.97 168.6 12.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.457 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 177.11 -43.48 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.796 0.331 . . . . 0.0 110.656 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -65.67 -111.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.973 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 13.7 t 72.79 -0.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 122.124 -0.36 . . . . 0.0 111.833 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.83 HG21 ' HD3' ' A' ' 6' ' ' ARG . 13.4 pt 47.36 178.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.155 0.503 . . . . 0.0 112.162 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.03 106.97 12.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.461 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.7 m -116.33 -32.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.622 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -53.62 90.67 0.01 OUTLIER Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.836 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t 173.4 -35.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.813 0.34 . . . . 0.0 110.985 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.96 102.33 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.221 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 38.1 m0 57.18 -86.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.229 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.42 82.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 111.13 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -159.84 174.55 14.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.492 ' H ' HG22 ' A' ' 54' ' ' THR . 12.0 p90 -114.89 86.92 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m 60.12 162.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -129.66 168.75 16.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -31.71 16.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.908 0.385 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.2 m -123.82 2.06 8.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.397 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.0 p -125.09 3.51 7.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.386 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.55 156.82 19.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.734 0.302 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.15 -65.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -164.89 48.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.81 -72.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -132.2 130.99 41.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -80.61 -50.99 1.03 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 94.2 Cg_endo -81.1 160.56 20.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.428 2.085 . . . . 0.0 112.418 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -177.98 4.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 13' ' ' VAL . 7.4 p -160.48 81.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.557 ' CG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -172.83 177.49 2.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.585 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.618 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -81.03 133.81 53.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.62 -7.68 21.11 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.634 2.223 . . . . 0.0 111.355 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.42 -19.82 10.52 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.155 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -139.18 87.55 13.76 Favored Pre-proline 0 CA--C 1.508 -0.638 0 CA-C-O 121.351 0.596 . . . . 0.0 109.51 175.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.53 39.78 0.5 Allowed 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 123.314 2.676 . . . . 0.0 110.168 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -146.96 -52.67 0.22 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.299 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.86 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -74.94 95.3 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.942 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' CG2' ' A' ' 14' ' ' THR . 1.8 mm -67.05 101.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.709 HD21 ' CG ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -34.01 138.66 0.08 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.619 0.247 . . . . 0.0 111.31 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' MET . 13.6 t -98.96 137.91 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' C ' ' O ' ' A' ' 31' ' ' ASP . 63.2 mt-10 -65.81 78.67 0.08 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.223 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 31' ' ' ASP . 62.4 m-20 -157.23 -123.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CD2' ' CG2' ' A' ' 40' ' ' VAL . 25.3 t80 71.97 68.2 0.14 Allowed 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.758 0.823 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.85 40.91 25.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.348 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.43 26.83 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 31' ' ' ASP . . . -95.54 20.91 47.39 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.208 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 26' ' ' ASP . 54.0 m-20 95.3 -92.36 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 122.734 0.414 . . . . 0.0 111.469 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.973 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 5.9 mtt -126.71 160.56 30.43 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 123.65 0.594 . . . . 0.0 111.702 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -146.3 139.2 20.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.789 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.3 t -102.19 102.31 23.89 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.6 Cg_endo -52.63 -6.83 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 114.52 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.155 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.2 mm-40 -102.06 -52.94 3.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.578 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.649 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.3 p -94.66 -32.05 13.56 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.05 31.71 28.06 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.702 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.136 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -65.91 -147.95 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.136 ' O ' HD12 ' A' ' 39' ' ' LEU . 45.5 t -150.02 169.83 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 40' ' ' VAL . 42.5 t -173.38 132.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.373 1.442 . . . . 0.0 109.793 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 129.27 150.04 6.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.66 -1.257 . . . . 0.0 113.746 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.31 127.98 6.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -106.64 101.29 10.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.785 ' O ' HD13 ' A' ' 46' ' ' ILE . 21.9 m -133.2 77.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.226 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 45' ' ' VAL . 1.3 mm -133.36 -72.94 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 41.94 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.844 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.6 m -69.37 177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.932 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.58 64.63 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 t 179.95 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -58.53 -20.41 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.7 m0 69.32 -61.43 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.083 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 77.0 107.67 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -154.98 -165.92 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' H ' HG22 ' A' ' 54' ' ' THR . 20.8 p90 -95.9 50.13 1.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.824 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m 62.07 177.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -106.75 134.22 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.39 -31.5 58.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.331 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -113.59 47.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 p -150.81 75.14 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.3 t -162.74 153.65 17.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.726 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -114.15 -70.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 173.22 40.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 77.2 -54.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.84 164.51 36.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.177 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -111.02 -55.29 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.594 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 48.9 Cg_endo -87.92 -80.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.433 2.089 . . . . 0.0 112.922 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.18 170.41 21.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.392 . . . . 0.0 111.117 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 14' ' ' THR . 22.1 t -121.9 -24.18 2.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.92 ' CG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -175.4 -179.61 1.32 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.86 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.757 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.91 135.21 52.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.97 -11.14 25.34 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.896 2.397 . . . . 0.0 110.432 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.5 t30 -102.78 -33.69 9.29 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.148 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.76 86.62 38.27 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.097 177.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.82 35.54 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.863 2.375 . . . . 0.0 110.069 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -153.76 -6.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.087 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -120.74 95.45 4.72 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.92 HD13 ' CG2' ' A' ' 14' ' ' THR . 4.2 mm -58.24 142.04 14.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 113.419 -1.719 . . . . 0.0 113.105 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 32' ' ' MET . 5.4 mp -65.39 158.08 27.59 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.8 t -111.79 138.55 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.179 0 O-C-N 120.13 -1.606 . . . . 0.0 109.052 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 mm-40 -60.69 86.0 0.01 OUTLIER 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.5 m-20 100.17 120.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 118.121 2.637 . . . . 0.0 118.121 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.623 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -131.59 118.58 20.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.281 176.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.1 ttm180 49.82 58.42 5.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.929 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 67.19 44.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.636 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -127.83 176.94 17.83 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.831 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.28 -64.45 1.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.376 0.608 . . . . 0.0 110.397 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 1.018 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.7 mtt -126.94 163.09 24.43 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.062 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.01 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -148.51 125.76 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.885 ' O ' ' N ' ' A' ' 38' ' ' GLY . 11.3 t -90.16 98.66 1.5 Allowed Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD3' HG23 ' A' ' 24' ' ' VAL . 4.1 Cg_endo -41.75 -9.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 124.568 3.512 . . . . 0.0 115.038 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.148 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.4 mm-40 -100.48 -88.44 0.36 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.732 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.7 p -55.55 -43.56 75.95 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 107.29 -10.19 39.37 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-O 121.729 0.627 . . . . 0.0 112.375 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.01 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -38.41 151.8 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.018 ' HA ' ' O ' ' A' ' 32' ' ' MET . 33.3 t -113.11 129.28 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.881 HG23 ' CD1' ' A' ' 39' ' ' LEU . 24.1 t -148.11 155.28 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.575 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 122.22 172.25 14.08 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.742 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.8 120.31 14.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 110.279 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' C ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -92.39 -71.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.263 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG23 ' C ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 61.7 169.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.917 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' H ' HG12 ' A' ' 45' ' ' VAL . 4.7 tt 42.18 86.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.688 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.83 -45.58 2.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.26 137.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.9 173.76 17.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.437 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.41 43.18 13.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.56 67.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.9 m0 61.16 -93.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 44.79 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.871 0.367 . . . . 0.0 111.366 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.56 -178.52 7.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 54' ' ' THR . 41.7 p90 -95.63 19.21 11.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.25 -177.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -117.75 -169.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.13 -45.48 13.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.92 0.391 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.97 -32.27 14.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 p -85.82 -29.57 23.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.489 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 34.6 t -58.38 134.4 56.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -69.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -177.3 125.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.44 128.09 34.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 58.78 177.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.978 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -88.91 -51.82 0.37 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD3' HD12 ' A' ' 10' ' ' LEU . 97.5 Cg_endo -87.64 -166.41 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.669 2.246 . . . . 0.0 112.379 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -125.49 -90.79 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.63 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 177.08 110.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.1 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.767 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.599 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -76.43 132.45 72.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.83 -16.38 54.44 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.594 2.196 . . . . 0.0 111.282 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -110.75 -14.04 14.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.314 0.578 . . . . 0.0 109.491 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.196 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -145.29 88.08 6.84 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 121.784 0.802 . . . . 0.0 109.845 175.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 78.5 Cg_endo -71.65 44.64 0.63 Allowed 'Trans proline' 0 CA--C 1.51 -0.692 0 C-N-CA 124.485 3.457 . . . . 0.0 109.41 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -149.37 -49.58 0.14 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.636 -1.62 . . . . 0.0 107.354 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.027 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -76.35 99.13 4.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.667 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.56 101.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.866 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 32' ' ' MET . 2.8 mp -39.82 147.15 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 0.0 111.855 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' MET . 16.4 t -99.26 135.17 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.655 0.74 . . . . 0.0 111.032 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -60.47 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.658 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 4.1 m-20 92.95 132.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.594 ' HB2' HG21 ' A' ' 33' ' ' ILE . 74.1 t80 -140.78 111.67 7.05 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.403 -1.272 . . . . 0.0 109.232 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.3 OUTLIER 65.53 53.56 1.22 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.782 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.1 33.94 14.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.613 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 26' ' ' ASP . . . -121.41 -163.35 11.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.857 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -98.5 -174.83 2.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.245 0.545 . . . . 0.0 110.908 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 23' ' ' LEU . 12.1 mtt -42.34 104.59 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.287 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -93.74 131.08 41.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.673 0.749 . . . . 0.0 110.73 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.804 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.1 t -95.42 100.52 6.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.01 -6.34 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.567 2.178 . . . . 0.0 114.407 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.196 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 59.5 mm-40 -100.21 -54.46 2.87 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' HD23 ' A' ' 39' ' ' LEU . 6.0 p -94.08 -24.99 17.36 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.9 31.14 54.51 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.63 -1.168 . . . . 0.0 113.12 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -63.53 -149.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.953 -0.623 . . . . 0.0 109.507 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 39' ' ' LEU . 55.5 t -161.81 152.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.788 HG23 HD11 ' A' ' 39' ' ' LEU . 96.0 t -163.68 145.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 120.627 1.558 . . . . 0.0 108.392 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 101.44 -163.75 17.82 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.4 t0 90.19 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.697 0.284 . . . . 0.0 111.152 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 105.42 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.049 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.645 HG13 ' OD2' ' A' ' 47' ' ' ASP . 6.2 p -104.21 145.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.523 HG23 ' N ' ' A' ' 47' ' ' ASP . 1.5 tp -55.51 -47.21 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.387 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' OD2' HG13 ' A' ' 45' ' ' VAL . 27.7 p30 21.31 68.54 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.995 0.518 . . . . 0.0 112.386 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.33 -34.41 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.69 62.3 6.48 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -172.48 35.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 53' ' ' ARG . 29.3 mm-40 -145.15 20.62 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.6 m0 66.16 -64.44 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.455 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 51' ' ' GLU . 4.4 tmt_? 76.12 94.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.941 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -153.28 -176.81 5.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.788 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.494 ' H ' HG22 ' A' ' 54' ' ' THR . 12.1 p90 -101.74 88.75 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.856 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 m 60.03 166.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.69 132.07 51.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -31.15 15.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.943 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -95.02 18.79 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.89 28.64 7.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 110.803 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.61 167.63 15.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -153.32 -74.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.88 119.33 32.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.33 37.49 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.764 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.24 26.16 9.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.392 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.93 -54.0 58.64 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.619 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -88.12 99.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.844 2.363 . . . . 0.0 112.085 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -49.44 125.55 11.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 14' ' ' THR . 30.6 m -86.35 58.68 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.89 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.909 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 68.7 p 117.32 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.49 1.116 . . . . 0.0 111.4 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -126.51 125.49 24.48 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 121.314 0.578 . . . . 0.0 112.276 177.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' CD ' ' A' ' 12' ' ' ARG . 44.1 Cg_endo -83.17 59.67 6.7 Favored 'Trans proline' 0 CA--C 1.507 -0.832 0 C-N-CA 123.842 3.028 . . . . 0.0 107.989 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.26 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.18 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.96 85.97 27.68 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.415 172.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.44 -18.52 31.92 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.203 1.935 . . . . 0.0 111.018 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -21.38 36.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.687 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -108.57 112.6 25.04 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.909 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 5.7 mt -81.62 132.26 31.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.853 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.95 142.11 57.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.69 0.757 . . . . 0.0 111.251 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.893 HG12 ' H ' ' A' ' 25' ' ' GLU . 13.5 t -82.74 -151.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 119.997 -1.689 . . . . 0.0 107.292 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.893 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.3 mt-10 -124.86 150.99 45.87 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER 69.92 179.79 0.24 Allowed 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.347 -178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 10.8 t80 173.46 83.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 7.1 mmm180 62.84 41.58 8.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 77.1 59.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.5 -177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.64 -143.43 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.25 -0.976 . . . . 0.0 115.153 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.39 -160.17 0.79 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.167 -1.016 . . . . 0.0 111.464 -178.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.912 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.1 mtt -68.44 125.22 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.82 -0.55 . . . . 0.0 110.452 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -106.93 140.03 26.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 123.761 0.825 . . . . 0.0 110.0 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' N ' HD13 ' A' ' 33' ' ' ILE . 9.0 t -104.02 106.19 52.02 Favored Pre-proline 0 N--CA 1.442 -0.831 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.9 Cg_endo -52.43 -10.0 0.72 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.534 2.156 . . . . 0.0 114.585 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.18 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -99.92 -52.66 3.37 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.155 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.606 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.3 p -93.96 -29.87 15.03 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.769 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 80.22 31.24 38.92 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.375 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -59.86 -157.71 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.105 -1.047 . . . . 0.0 110.39 -178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.912 ' HA ' ' O ' ' A' ' 32' ' ' MET . 69.3 t -160.56 131.58 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 123.773 0.67 . . . . 0.0 110.054 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 HD22 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -138.61 142.61 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.78 0.324 . . . . 0.0 110.958 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 104.65 -168.82 16.45 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 9.5 t70 96.01 -15.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.539 0.209 . . . . 0.0 111.319 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.7 156.9 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.146 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 t -54.08 92.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.361 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 46' ' ' ILE . 5.4 tt -132.02 101.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.062 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -178.29 111.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.82 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.33 -74.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.94 96.97 0.01 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.78 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 t -151.31 35.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.2 mm-40 -131.9 36.27 3.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m-90 67.07 -63.77 0.27 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.276 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.7 tmt_? 75.77 99.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -161.83 170.61 19.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 54' ' ' THR . 9.7 p90 -110.05 54.84 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.38 -172.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -117.37 159.86 22.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.61 -34.12 17.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.938 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.796 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 m -110.21 -32.24 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 51.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.77 120.01 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.98 102.07 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.816 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 7' ' ' LEU . 3.7 tp 61.23 -168.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -142.58 -49.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.025 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -178.79 106.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.06 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER -100.44 -9.0 0.12 Allowed Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 73.8 Cg_endo -77.79 -48.09 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.413 1.409 . . . . 0.0 112.537 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -176.75 -59.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.221 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 70.79 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.774 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 55.38 175.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.979 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.658 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -77.91 130.02 74.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 31.1 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.718 2.278 . . . . 0.0 110.57 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.91 -36.91 14.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.142 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -130.89 87.47 48.94 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.212 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.06 -10.47 12.67 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.038 1.825 . . . . 0.0 111.202 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.35 -51.82 5.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.15 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.025 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -73.57 105.14 4.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.596 0.712 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 22' ' ' ILE . 3.3 mp -76.17 99.48 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.845 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD22 HG23 ' A' ' 41' ' ' VAL . 3.9 mp -34.42 142.94 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.085 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 32' ' ' MET . 12.7 t -98.2 140.96 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.833 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.3 mt-10 -66.29 72.49 0.08 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.606 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.877 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.6 p30 157.98 179.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.67 ' HB2' ' CB ' ' A' ' 33' ' ' ILE . 4.8 t80 147.46 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.962 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.48 47.37 1.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.502 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.28 48.77 2.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.77 -162.41 11.62 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.846 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.877 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -90.09 -102.4 0.1 Allowed 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.281 -0.959 . . . . 0.0 112.69 -178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.785 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 15.1 mtm -117.64 104.44 11.02 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.656 0.741 . . . . 0.0 112.332 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.797 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -95.62 132.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.339 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.804 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.2 t -94.27 103.62 11.32 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.1 Cg_endo -49.45 -13.4 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 114.51 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.142 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.5 mm-40 -98.7 -55.34 2.76 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.908 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.9 p -94.16 -24.26 17.6 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.01 28.26 60.87 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.961 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.708 HD11 ' CG2' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -59.59 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.676 -179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.836 HG12 ' OD2' ' A' ' 31' ' ' ASP . 61.5 t -164.92 127.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.834 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER -142.18 151.67 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.098 0.475 . . . . 0.0 111.783 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.41 155.75 10.54 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.472 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -157.2 33.01 0.29 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.823 0.344 . . . . 0.0 110.75 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -56.71 128.6 37.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -176.24 130.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 47' ' ' ASP . 17.5 tt -171.32 -47.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.494 ' N ' HG23 ' A' ' 46' ' ' ILE . 22.5 m-20 50.72 99.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.35 131.32 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.07 115.48 5.01 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.54 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.346 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 21.6 mm-40 -58.5 -19.9 41.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 6.3 m0 67.66 -65.06 0.25 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.177 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 67.6 92.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 3.4 m -163.74 169.45 18.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 55.3 p90 -76.58 -2.49 32.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.476 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.8 m 73.95 165.14 0.29 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.886 0.374 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 124.94 21.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.935 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.88 -29.77 44.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.828 0.346 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -153.71 73.34 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 115.51 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 -60.64 1.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.7 -172.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.732 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.787 HD22 ' HG ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -45.82 100.59 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.213 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 5.3 p30 -104.64 71.23 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' PRO . . . 179.25 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.266 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.787 ' HG ' HD22 ' A' ' 7' ' ' LEU . 4.6 mt 15.39 -79.81 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 10' ' ' LEU . 65.7 Cg_endo -75.97 -54.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 168.77 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.404 HG13 ' OG1' ' A' ' 14' ' ' THR . 12.5 p -160.52 -29.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.674 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.645 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -170.27 173.53 5.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.194 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.603 ' SG ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.42 129.58 74.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.32 -18.28 61.81 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.587 2.191 . . . . 0.0 111.217 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -107.99 -14.95 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.473 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.199 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -148.87 84.6 6.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 CA-C-O 121.608 0.718 . . . . 0.0 109.962 175.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' O ' HG21 ' A' ' 14' ' ' THR . 11.0 Cg_endo -56.02 -11.96 6.49 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.14 2.56 . . . . 0.0 111.291 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.02 -47.48 8.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.459 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -75.56 100.42 4.56 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.059 0.457 . . . . 0.0 111.709 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 22' ' ' ILE . 1.5 mp -72.31 95.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.768 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 41' ' ' VAL . 3.3 mp -34.85 147.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.249 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 32' ' ' MET . 10.7 t -99.76 133.01 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.581 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 97.6 mt-10 -62.0 84.15 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.837 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.688 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 20.0 t70 125.01 103.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.3 OUTLIER -88.4 102.9 15.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.029 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 46.21 49.57 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.73 35.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.333 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -136.56 -127.93 2.67 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.83 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -104.56 -174.85 2.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.44 0.638 . . . . 0.0 111.81 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.895 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -48.76 107.73 0.15 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.905 -178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -96.62 131.07 44.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.134 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.775 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 t -98.06 98.48 5.6 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.82 -7.68 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.48 2.12 . . . . 0.0 114.223 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.199 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 55.2 mm-40 -97.78 -57.25 2.28 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.382 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.739 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 7.1 p -92.93 -29.19 16.01 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.775 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.54 30.09 37.64 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.499 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.754 HD11 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -63.4 -154.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.895 ' HA ' ' O ' ' A' ' 32' ' ' MET . 98.5 t -163.05 123.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 123.52 0.512 . . . . 0.0 109.671 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -133.41 139.3 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.931 0.396 . . . . 0.0 111.387 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.3 -153.78 16.74 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 33.2 t70 64.63 76.77 0.33 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.919 0.39 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -86.25 73.61 10.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.81 135.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.641 HG23 ' CG2' ' A' ' 48' ' ' VAL . 20.1 tt -167.68 154.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.033 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.59 -47.55 83.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.378 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.641 ' CG2' HG23 ' A' ' 46' ' ' ILE . 35.0 t 69.84 159.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.968 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -49.97 -95.22 0.01 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.67 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.2 80.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -96.91 22.77 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.1 m0 61.82 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 57.56 69.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.865 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -115.44 -168.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.889 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' HG22 ' A' ' 54' ' ' THR . 15.8 p90 -92.01 50.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.5 m 62.64 147.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -59.68 115.36 3.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.04 -30.63 66.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.823 0.344 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -72.31 -11.63 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.397 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.4 p -53.26 -71.34 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.767 0.318 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 96.64 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.756 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -29.27 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.058 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -111.26 60.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.838 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.46 64.14 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.32 79.75 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.027 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.01 156.41 74.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.53 108.4 2.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.484 2.123 . . . . 0.0 112.192 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.42 -59.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 14' ' ' THR . 4.5 p 32.28 -112.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.402 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.961 HG22 ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER 153.51 -155.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -124.15 122.13 26.15 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.63 61.74 7.65 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 C-N-CA 123.918 3.078 . . . . 0.0 107.326 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.01 -40.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.168 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.42 83.26 32.01 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.098 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.63 -13.81 27.86 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.145 1.897 . . . . 0.0 111.4 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -94.12 -17.85 22.37 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.873 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -114.13 89.7 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.589 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.961 ' CD1' HG22 ' A' ' 14' ' ' THR . 1.2 mm -61.32 141.83 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.167 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 39' ' ' LEU . 2.1 mp -61.22 142.32 56.88 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.77 136.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.593 -1.317 . . . . 0.0 111.444 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.94 124.85 3.99 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.424 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.818 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER 70.91 -179.14 0.22 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.378 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 3.0 m-85 121.81 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.139 0.971 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 61.5 52.68 3.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.345 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 54.82 23.71 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.82 -179.99 35.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.183 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 18.9 m-20 -98.1 -44.04 6.78 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.322 1.058 . . . . 0.0 108.233 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.769 ' O ' HD23 ' A' ' 23' ' ' LEU . 40.0 mtt -151.58 115.59 4.97 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.005 -1.907 . . . . 0.0 108.846 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -100.99 152.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.797 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.4 t -107.24 104.22 51.45 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -48.06 -14.66 0.31 Allowed 'Trans proline' 0 CA--C 1.516 -0.414 0 C-N-CA 122.896 2.397 . . . . 0.0 114.788 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.168 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 16.4 mm-40 -97.46 -55.84 2.71 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.493 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.466 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 4.1 p -91.45 -33.17 15.33 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.797 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 83.65 26.77 41.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.699 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 1.2 pp -54.15 -159.33 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.801 -1.2 . . . . 0.0 109.593 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 39' ' ' LEU . 53.8 t -154.54 134.02 3.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 O-C-N 123.631 0.582 . . . . 0.0 110.417 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.853 HG23 HD11 ' A' ' 39' ' ' LEU . 59.2 t -138.42 137.26 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 111.495 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ASP . . . 118.39 158.18 10.76 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.731 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 2.4 m-20 148.74 -33.06 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.124 0.57 . . . . 0.0 109.656 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -39.35 152.63 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.908 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -56.03 110.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.215 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.661 HD13 HD13 ' A' ' 7' ' ' LEU . 9.1 tp -177.97 111.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.039 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -164.31 98.75 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -148.94 145.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.34 62.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.71 35.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -112.67 114.77 27.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m0 58.83 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 45.53 81.02 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.68 0.276 . . . . 0.0 111.259 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -155.03 135.4 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 50.2 p90 -62.07 115.84 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m 63.26 140.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.72 135.99 57.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -76.98 -66.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.814 0.34 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -62.51 -31.5 72.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.9 p -65.18 -71.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.13 129.69 40.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -60.34 -37.47 80.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 7' ' ' LEU . 21.1 mt -101.34 -177.28 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.736 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -134.71 -52.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.98 65.1 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.642 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 20.7 mt 57.89 164.35 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.047 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 3.3 Cg_endo -46.01 -72.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.952 2.435 . . . . 0.0 112.639 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 174.79 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 111.121 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.4 m -130.81 122.87 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.674 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.706 HG23 ' CD1' ' A' ' 22' ' ' ILE . 0.2 OUTLIER 80.56 -135.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -128.11 127.33 23.82 Favored Pre-proline 0 C--N 1.333 -0.135 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 176.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 -28.98 66.23 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.53 2.153 . . . . 0.0 110.739 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -86.29 -28.39 23.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.119 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.02 87.36 29.61 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.016 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.35 40.95 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.995 2.463 . . . . 0.0 109.222 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' HIS . 2.6 m-20 -150.96 -25.38 0.21 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.393 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.886 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -110.49 97.22 6.72 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.706 ' CD1' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -64.73 130.02 29.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD22 HG23 ' A' ' 41' ' ' VAL . 1.6 mp -50.53 142.93 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.032 0.378 . . . . 0.0 110.751 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . 57.5 t -94.24 120.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.568 0.699 . . . . 0.0 111.332 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.053 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 mm-40 -13.46 -112.16 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' C ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -57.53 102.37 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -178.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.23 100.61 0.81 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.591 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 51.63 41.48 28.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 84.05 49.92 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.889 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' C ' ' HA ' ' A' ' 26' ' ' ASP . . . -139.51 -119.59 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.624 -0.798 . . . . 0.0 114.259 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.798 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -104.47 -74.31 0.65 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 1.053 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 45.4 mtt -156.73 109.6 2.57 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.426 0.631 . . . . 0.0 112.6 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.909 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -98.18 150.36 4.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.351 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 5.5 t -103.61 107.51 56.48 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.8 Cg_endo -52.12 -13.68 2.12 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.561 2.174 . . . . 0.0 114.63 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.119 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 63.9 mm-40 -100.0 -51.0 3.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.975 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.611 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.5 p -96.61 -30.14 13.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.909 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 81.59 27.44 47.25 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.511 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.63 -151.63 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.982 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.4 t -160.3 135.6 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.9 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -148.62 154.75 9.7 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.64 155.12 15.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.849 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.57 88.42 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.66 100.46 11.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.35 42.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -51.3 -60.42 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.606 ' H ' HG23 ' A' ' 46' ' ' ILE . 3.6 m-20 43.12 29.48 0.21 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 46' ' ' ILE . 95.1 t -140.91 -85.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.55 93.32 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.807 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -161.27 105.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 179.42 61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 30.2 m0 62.38 -82.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.78 69.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -161.86 179.64 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 54' ' ' THR . 14.2 p90 -105.17 71.63 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.92 161.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.845 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -110.32 175.94 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -109.85 -33.34 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.338 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -98.87 32.53 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.52 -28.86 9.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.29 -177.67 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -119.82 -79.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.774 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 6.3 mt -136.63 -101.11 0.2 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.59 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 4.1 p30 164.86 37.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.445 0.164 . . . . 0.0 111.214 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 8' ' ' ASP . . . 172.5 176.13 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 111.629 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -101.41 165.56 13.88 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 10' ' ' LEU . 3.3 Cg_exo -36.71 116.04 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.293 2.662 . . . . 0.0 112.573 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 11' ' ' PRO . 0.4 OUTLIER 51.57 175.18 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.96 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.73 -92.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -67.03 -173.67 0.27 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.729 0.776 . . . . 0.0 112.446 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.579 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER -72.43 134.3 82.39 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -176.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 41.7 Cg_endo -83.39 81.51 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.664 0 N-CA-C 103.249 -3.404 . . . . 0.0 103.249 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.594 ' HB3' ' HD1' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 158.84 -44.42 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -175.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.159 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.3 83.44 32.24 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.934 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.74 26.67 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.776 2.317 . . . . 0.0 110.585 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER -145.17 -7.64 0.62 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.838 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.731 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -121.99 78.73 1.5 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.801 ' HA ' HG22 ' A' ' 14' ' ' THR . 3.1 mt -38.91 167.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.703 -1.59 . . . . 0.0 113.291 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD11 HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -88.99 142.49 27.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 173.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.84 127.28 69.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 120.442 -1.411 . . . . 0.0 110.384 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -51.2 118.7 3.41 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.891 0.853 . . . . 0.0 111.744 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER 91.34 177.05 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.313 -1.767 . . . . 0.0 112.893 178.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 26' ' ' ASP . 43.7 m-85 109.26 129.33 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.707 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.9 44.6 13.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.459 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 52.15 32.67 10.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -111.99 165.18 12.07 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.189 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -73.33 -47.53 41.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.067 0.936 . . . . 0.0 108.676 178.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.881 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 1.8 mtm -144.22 150.43 37.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 112.895 -1.957 . . . . 0.0 110.226 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.836 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -138.18 136.52 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' O ' ' N ' ' A' ' 38' ' ' GLY . 36.5 t -101.19 103.99 29.8 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 22' ' ' ILE . 4.0 Cg_endo -43.69 -14.91 0.06 OUTLIER 'Trans proline' 0 CA--C 1.503 -1.066 0 C-N-CA 124.742 3.628 . . . . 0.0 115.342 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.159 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.3 mm-40 -95.15 -74.44 0.55 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.707 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 1.8 p -69.17 -49.16 59.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.844 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 100.2 13.3 36.65 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.123 -1.037 . . . . 0.0 111.779 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -56.78 -173.15 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.131 -0.535 . . . . 0.0 111.968 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.881 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -138.38 134.46 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 O-C-N 125.434 1.709 . . . . 0.0 113.128 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.751 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -153.04 166.87 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.393 178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 108.86 174.81 21.51 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.376 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.556 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . 0.2 OUTLIER 67.28 118.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.914 0.388 . . . . 0.0 111.331 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.01 73.49 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.607 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.56 172.71 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.379 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.849 HG23 HG23 ' A' ' 48' ' ' VAL . 2.5 tt 177.17 -33.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 77.14 59.12 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 46' ' ' ILE . 93.9 t -98.91 100.76 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.16 87.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.536 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -141.83 26.9 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.678 0.275 . . . . 0.0 111.025 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.42 6.58 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 49.4 m0 67.47 -63.19 0.31 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.619 0.247 . . . . 0.0 111.275 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 76.61 98.4 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 55' ' ' PHE . 1.1 m -157.66 173.3 17.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.771 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.484 ' H ' HG22 ' A' ' 54' ' ' THR . 37.9 p90 -102.35 50.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 0.0 110.865 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m 62.42 149.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.03 165.75 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.09 -35.6 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.799 0.333 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -125.56 67.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 4' ' ' THR . 27.7 m -143.16 28.56 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.82 -38.9 15.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.95 159.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.88 148.63 29.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.865 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -73.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.92 139.45 35.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.78 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.6 mt 179.14 -63.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.744 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 61.0 Cg_endo -87.91 -31.62 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.59 2.193 . . . . 0.0 112.97 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.48 97.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.556 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.22 149.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.557 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.47 179.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -82.65 130.32 58.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.92 -12.66 35.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.037 2.491 . . . . 0.0 111.543 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.05 -19.55 12.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.177 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -143.23 88.51 8.1 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-O 121.251 0.548 . . . . 0.0 110.787 176.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.85 33.62 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.162 3.241 . . . . 0.0 110.254 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -135.5 -49.14 0.71 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.124 -1.398 . . . . 0.0 107.714 179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -78.91 95.57 5.47 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.118 0.961 . . . . 0.0 111.188 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.68 97.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 111.702 -2.499 . . . . 0.0 112.436 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -36.72 131.82 0.68 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.974 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' GLU . 6.2 t -80.85 171.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.152 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -104.46 89.8 3.34 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.246 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.0 m-20 157.6 94.69 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 O-C-N 123.795 0.684 . . . . 0.0 110.439 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 29' ' ' ALA . 2.4 p90 -98.99 -159.44 0.74 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -41.06 -29.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.56 0.219 . . . . 0.0 111.41 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . . . -119.91 -85.93 0.65 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.15 62.45 0.3 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.473 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 26' ' ' ASP . 74.3 m-20 -139.24 -109.72 0.16 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 11.2 mtt -134.86 154.19 51.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 112.256 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -149.46 138.39 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.512 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.826 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 t -104.7 102.63 35.8 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 2.67 0.07 OUTLIER 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 122.456 2.104 . . . . 0.0 114.744 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.177 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -108.8 -53.52 2.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.412 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.797 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 3.7 p -92.2 -39.17 11.7 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 85.56 40.01 7.99 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 113.928 -1.487 . . . . 0.0 112.824 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.008 HD12 ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -72.34 -151.94 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 39' ' ' LEU . 88.1 t -150.09 165.96 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG23 HD11 ' A' ' 39' ' ' LEU . 73.4 t -171.31 124.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 119.543 1.065 . . . . 0.0 109.289 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.69 171.62 13.07 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.351 -1.404 . . . . 0.0 113.252 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.17 -68.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 110.169 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.42 32.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.27 -81.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.451 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 tt -178.45 163.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.763 0.316 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.97 103.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.961 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -78.47 106.69 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.032 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.32 74.43 0.21 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.626 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.85 32.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.749 0.309 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 17.4 mm-40 -127.74 -0.51 6.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.638 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.0 m0 67.78 -60.07 0.4 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.547 0.213 . . . . 0.0 111.435 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.6 tmt_? 81.39 105.94 0.06 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.936 0.398 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -162.43 -178.8 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.613 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' HG22 ' A' ' 54' ' ' THR . 10.2 p90 -103.75 84.46 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.3 m 59.76 -178.19 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -138.2 164.74 28.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.96 -31.51 11.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.982 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.75 0.309 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -98.56 28.86 3.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -33.38 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 m -100.77 -174.58 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.824 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.71 ' O ' HD12 ' A' ' 7' ' ' LEU . 6.4 mtp85 -105.28 -82.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -161.12 -95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 161.86 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.714 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' LEU . . . 56.76 164.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.557 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.551 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.1 tt 164.46 -52.8 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.141 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.415 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 46.4 Cg_endo -68.63 66.52 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.31 2.007 . . . . 0.0 112.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 2.1 mpt_? 62.74 116.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.243 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.9 m -83.57 92.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.642 HG23 HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER 72.33 -172.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.008 -178.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.642 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -87.1 132.12 42.57 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.29 -20.73 36.68 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.676 2.25 . . . . 0.0 110.302 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.39 -31.03 15.47 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.069 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -134.7 87.08 32.07 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.981 177.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.92 30.06 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.617 2.212 . . . . 0.0 110.226 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.7 m-20 -151.9 2.63 0.38 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.012 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.879 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -125.81 92.35 3.58 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG23 HG23 ' A' ' 14' ' ' THR . 1.1 mm -63.76 106.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 112.772 -2.013 . . . . 0.0 113.093 -175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD11 HD21 ' A' ' 39' ' ' LEU . 1.4 mp -34.66 159.24 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 32' ' ' MET . 4.6 t -92.94 177.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 O-C-N 119.276 -2.14 . . . . 0.0 107.179 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.738 ' O ' ' N ' ' A' ' 32' ' ' MET . 0.9 OUTLIER -77.93 -63.3 1.42 Allowed 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.343 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.705 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 1.1 m-20 -109.6 117.35 33.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.771 ' N ' ' O ' ' A' ' 31' ' ' ASP . 1.5 p90 -76.91 108.1 9.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.563 0.697 . . . . 0.0 111.99 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.637 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER 40.18 33.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 112.102 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 122.49 -27.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 111.097 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -91.87 -150.1 25.11 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.852 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.771 ' O ' ' N ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -85.55 -165.79 1.33 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.027 0.531 . . . . 0.0 111.391 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.83 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 17.9 mtp -42.97 155.85 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.819 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.45 123.95 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 124.912 1.285 . . . . 0.0 107.542 -178.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.785 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -87.63 99.24 1.19 Allowed Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 33' ' ' ILE . 6.8 Cg_endo -47.21 -18.65 0.74 Allowed 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.919 2.413 . . . . 0.0 113.771 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.069 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 28.5 mm-40 -93.42 -58.91 2.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.247 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.514 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 4.0 p -89.96 -33.2 16.48 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 117.203 -1.799 . . . . 0.0 106.396 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 84.14 44.88 6.47 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-O 121.544 0.524 . . . . 0.0 113.547 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 1.4 pp -85.79 -174.25 5.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.482 -0.859 . . . . 0.0 108.705 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.697 HG12 ' OD2' ' A' ' 31' ' ' ASP . 95.6 t -142.51 127.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.5 t -143.58 130.49 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . 140.32 160.71 8.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.69 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -179.94 -59.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.413 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.7 OUTLIER 70.51 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.301 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER 153.0 -23.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.961 0.505 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 46' ' ' ILE . 19.1 tt -40.53 104.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 112.077 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -117.09 -33.96 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.75 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 49' ' ' GLY . 10.2 p -119.99 158.93 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' N ' HG22 ' A' ' 48' ' ' VAL . . . -144.57 146.92 17.84 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.482 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -176.87 86.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 111.013 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -113.17 39.24 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.9 m0 60.1 -86.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? 45.69 71.4 0.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.858 0.361 . . . . 0.0 111.343 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 173.62 10.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.998 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -113.64 34.58 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.29 150.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -85.0 177.31 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.881 0.372 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m -59.74 -28.28 67.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.7 p -58.47 -52.44 65.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -171.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -41.65 3.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.33 151.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.83 -79.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.371 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.01 125.08 25.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 8.7 mt -101.14 -52.58 0.17 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.627 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.692 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 83.3 Cg_endo -92.97 -100.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.625 2.217 . . . . 0.0 112.778 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.31 148.72 0.37 Allowed 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 13' ' ' VAL . 35.7 m -142.71 123.08 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 111.982 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.733 HG21 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 71.68 169.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.078 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.636 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -66.67 129.88 94.08 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -177.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.49 -31.64 50.82 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.364 2.043 . . . . 0.0 109.775 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 -32.71 31.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.182 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -137.87 88.03 16.29 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.171 177.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' HG21 ' A' ' 14' ' ' THR . 13.1 Cg_endo -56.44 -19.38 28.73 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.273 1.982 . . . . 0.0 110.701 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.77 -16.35 41.86 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.006 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -109.71 123.39 49.43 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.552 -0.717 . . . . 0.0 109.331 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -93.18 120.38 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.873 -178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.5 mp -51.61 137.65 24.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.042 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -97.68 141.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.921 0.867 . . . . 0.0 111.705 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.27 150.22 22.35 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.039 -1.437 . . . . 0.0 111.037 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASP . 7.1 t70 28.17 102.66 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.004 -1.907 . . . . 0.0 114.688 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 t80 -121.68 121.01 36.38 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.043 176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 42.08 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.702 -177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 48.39 4.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.025 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -128.58 -159.77 10.1 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.871 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.785 ' OD2' HG12 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -85.7 -93.61 0.08 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.211 -0.994 . . . . 0.0 109.558 179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.971 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 27.4 mtp -126.66 151.42 48.09 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -137.36 137.57 45.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.801 ' O ' ' N ' ' A' ' 38' ' ' GLY . 7.0 t -95.32 105.77 22.08 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.21 -11.93 1.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.202 1.934 . . . . 0.0 114.138 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.182 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 70.7 mm-40 -98.84 -52.4 3.59 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.197 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.727 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 6.4 p -96.31 -24.68 16.07 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.21 29.89 55.69 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.287 -1.324 . . . . 0.0 113.612 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -58.09 -151.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.792 -0.704 . . . . 0.0 109.819 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.971 ' HA ' ' O ' ' A' ' 32' ' ' MET . 58.1 t -164.21 136.94 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.496 0.188 . . . . 0.0 110.554 177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.834 HG23 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -150.13 157.19 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-O 121.096 0.474 . . . . 0.0 111.884 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.79 155.97 11.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.311 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.73 -59.24 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.067 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.01 178.6 4.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -147.78 162.84 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.775 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.402 ' N ' HG13 ' A' ' 45' ' ' VAL . 17.6 tt -76.36 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -150.07 -68.09 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t 62.72 118.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.44 45.96 2.01 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.622 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -135.93 16.75 3.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.605 0.241 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 1.3 mm-40 -131.01 -10.96 3.78 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 5.6 m-90 69.88 -57.91 0.54 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 0.0 111.293 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 78.57 91.34 0.06 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.78 129.53 14.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -96.45 125.14 40.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 m 61.56 90.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.53 151.22 24.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.25 -34.66 10.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.835 0.35 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.0 m -70.09 -22.64 63.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.082 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -54.36 -29.24 47.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 t -92.22 90.53 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -69.97 -76.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.808 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.98 97.86 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.703 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -89.84 53.32 2.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 179.87 166.0 1.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 111.435 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -80.46 168.21 27.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 10' ' ' LEU . 4.6 Cg_exo -39.56 -32.72 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.943 2.428 . . . . 0.0 112.465 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.5 133.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -104.63 -8.98 9.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.507 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.705 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.81 153.4 24.46 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.161 0.505 . . . . 0.0 110.7 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -64.12 146.92 97.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 78.6 Cg_endo -78.88 -15.21 13.39 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.856 2.37 . . . . 0.0 110.511 177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.529 ' C ' ' ND1' ' A' ' 18' ' ' HIS . 19.6 m-20 -122.02 35.83 4.78 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.022 ' CD2' ' HB2' ' A' ' 36' ' ' GLU 0.317 0.0 OUTLIER 172.87 73.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.03 172.68 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 73.4 Cg_endo -71.53 39.85 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 125.269 3.979 . . . . 0.0 109.166 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 18' ' ' HIS . 3.4 m-20 -146.2 -44.29 0.2 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.685 -1.598 . . . . 0.0 107.937 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -79.29 136.3 36.99 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.023 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 14' ' ' THR . 22.6 pt -107.05 48.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' HG ' ' CA ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER 18.92 75.65 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 24' ' ' VAL . 2.6 t -54.38 135.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 CA-C-O 122.282 1.039 . . . . 0.0 111.012 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 2.5 mt-10 -82.64 101.62 10.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.993 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.787 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 133.2 69.48 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 124.805 1.316 . . . . 0.0 112.057 176.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.02 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.7 p90 -89.6 -45.51 9.31 Favored 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 123.954 0.784 . . . . 0.0 110.937 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG ' ' A' ' 27' ' ' TYR . 43.3 ttt180 -155.24 -59.18 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.15 63.69 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' ASP . . . 128.67 -30.02 3.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.959 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.787 ' O ' ' N ' ' A' ' 26' ' ' ASP . 31.2 m-20 -51.67 -157.3 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.902 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.5 mtm -98.88 126.97 44.68 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.791 0.836 . . . . 0.0 112.662 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.02 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -119.77 106.63 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.92 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -57.76 105.09 0.48 Allowed Pre-proline 0 C--O 1.218 -0.596 0 O-C-N 121.422 -0.799 . . . . 0.0 111.779 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' HB1' ' A' ' 21' ' ' ALA . 11.6 Cg_endo -57.25 -2.61 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 121.063 1.175 . . . . 0.0 113.504 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.022 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 64.2 mm-40 -112.79 -38.76 4.47 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.655 ' SG ' HD23 ' A' ' 39' ' ' LEU . 15.3 p -114.04 3.26 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 172.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.92 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 38.61 50.39 2.44 Favored Glycine 0 N--CA 1.411 -2.971 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.805 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 41' ' ' VAL 0.264 1.4 pp -91.57 160.36 15.45 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.902 ' HA ' ' O ' ' A' ' 32' ' ' MET . 6.3 t -118.27 140.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 121.89 2.132 . . . . 0.0 109.968 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 39' ' ' LEU . 61.6 t -135.85 125.13 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.953 0.406 . . . . 0.0 111.42 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.9 160.7 8.4 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.557 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 -82.53 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.802 0.334 . . . . 0.0 110.365 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.52 73.46 0.22 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 0.0 110.656 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 m -96.7 38.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.63 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -72.64 65.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.694 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -52.32 -47.36 66.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.577 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.27 -77.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.212 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.08 -165.29 0.08 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.881 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 t 178.04 65.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -135.45 21.46 3.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.285 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 5.5 m0 64.03 -72.27 0.06 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.289 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 72.62 65.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 110.688 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -177.75 -170.84 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.706 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 25.1 p90 -97.57 74.04 2.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.1 0.476 . . . . 0.0 110.881 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m 64.52 -177.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -91.51 163.31 14.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.19 -46.34 90.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.853 0.359 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -62.37 -71.31 0.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.703 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -77.01 92.39 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -172.44 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 5' ' ' SER . 2.7 ttt85 79.24 15.31 1.0 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.0 tp 46.63 74.98 0.13 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.729 0.3 . . . . 0.0 110.967 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.27 -169.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 10' ' ' LEU . . . -68.66 -92.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.686 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.633 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -152.16 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.836 -0.165 . . . . 0.0 111.141 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 66.3 Cg_endo -89.1 -168.35 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.351 2.034 . . . . 0.0 112.417 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.7 125.61 27.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.387 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.056 ' O ' HG23 ' A' ' 14' ' ' THR . 12.5 p -67.0 111.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.605 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.056 HG23 ' O ' ' A' ' 13' ' ' VAL . 3.9 p 162.76 -159.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.175 0.99 . . . . 0.0 109.049 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.769 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -108.45 136.24 19.91 Favored Pre-proline 0 C--O 1.233 0.197 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.5 Cg_endo -75.51 14.38 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.564 2.843 . . . . 0.0 110.806 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.487 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 1.7 t-20 -131.29 -37.54 1.24 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.114 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.61 86.76 38.71 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.374 176.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 14' ' ' THR . 11.7 Cg_endo -55.95 -23.65 44.15 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.746 1.631 . . . . 0.0 110.516 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.83 -30.4 16.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.52 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -92.55 62.03 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.58 1.181 . . . . 0.0 112.601 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.86 HG12 HG22 ' A' ' 14' ' ' THR . 3.5 mt -35.04 136.36 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 111.913 -2.403 . . . . 0.0 111.339 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD21 ' HG ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -66.45 128.38 35.98 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.491 0.662 . . . . 0.0 111.057 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' HD3' ' A' ' 35' ' ' PRO . 10.9 t -81.62 152.38 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.724 0.773 . . . . 0.0 112.29 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -65.25 94.52 0.16 Allowed 'General case' 0 CA--C 1.496 -1.103 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.287 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.829 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.6 p30 162.87 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 160.59 77.56 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.693 178.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER 48.16 17.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 158.56 -68.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.686 0.394 . . . . 0.0 110.245 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.848 ' O ' ' HB3' ' A' ' 27' ' ' TYR . . . -139.43 172.31 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.426 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 26' ' ' ASP . 3.2 m-20 87.64 -173.03 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.829 ' HA ' ' H ' ' A' ' 26' ' ' ASP . 15.8 mtp -122.48 142.72 50.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.567 1.531 . . . . 0.0 109.993 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -105.6 120.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.139 0.971 . . . . 0.0 111.374 -177.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 3.9 t -75.63 104.72 1.58 Allowed Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.992 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HD3' HG23 ' A' ' 24' ' ' VAL . 22.7 Cg_endo -59.15 5.23 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.285 1.99 . . . . 0.0 114.662 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.114 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 79.8 mm-40 -117.48 -42.75 2.85 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.391 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.0 p -101.98 -17.64 16.01 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 172.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 66.72 41.5 93.74 Favored Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -90.18 155.39 19.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 113.705 -1.248 . . . . 0.0 111.153 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 27' ' ' TYR . 94.8 t -104.39 135.89 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.239 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 39' ' ' LEU . 13.8 t -146.94 130.48 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.44 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.72 -176.78 20.95 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.674 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -165.22 -68.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.858 0.361 . . . . 0.0 110.08 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' C ' HG12 ' A' ' 45' ' ' VAL . 3.1 ttm105 55.55 168.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.591 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.649 HG22 ' N ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER 172.09 -82.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.558 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.649 ' N ' HG22 ' A' ' 45' ' ' VAL . 5.4 tp 43.88 115.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.469 0.652 . . . . 0.0 112.579 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.44 107.35 3.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.735 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 51' ' ' GLU . 28.9 m -96.6 -178.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.47 26.6 2.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.2 m -150.75 28.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.708 0.29 . . . . 0.0 111.02 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' HG21 ' A' ' 48' ' ' VAL . 14.4 mm-40 -107.3 -26.4 11.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.423 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 24.1 m0 66.37 -65.87 0.19 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.249 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? 64.83 109.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.15 176.5 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 54' ' ' THR . 5.2 p90 -107.09 78.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m 61.3 162.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.46 130.22 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.87 -61.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.905 0.383 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 m -98.76 30.94 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.0 p -119.57 30.49 7.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.78 -171.77 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -142.62 -79.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.4 -84.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 172.18 -50.05 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.72 124.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.0 mt -74.08 -48.93 5.88 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.587 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 74.0 Cg_endo -75.45 158.39 40.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.314 2.009 . . . . 0.0 112.437 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 18.18 1.8 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.466 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.031 ' O ' HG23 ' A' ' 14' ' ' THR . 4.2 m 31.8 95.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 13' ' ' VAL . 9.2 p 151.06 -144.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.512 1.125 . . . . 0.0 108.845 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.732 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 2.6 t -123.69 135.78 26.57 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 118.218 0.463 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 90.1 Cg_endo -71.92 15.73 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.231 2.621 . . . . 0.0 110.822 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' CYS . 2.0 t30 -135.53 -40.78 0.71 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.133 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -124.25 88.92 52.49 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.259 177.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.54 11.53 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.353 2.035 . . . . 0.0 111.23 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -122.98 -36.77 2.81 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.882 179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.828 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -88.03 49.86 1.88 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.874 HG13 HG22 ' A' ' 14' ' ' THR . 1.9 mp -29.72 117.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.386 -177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 32' ' ' MET . 1.4 mp -37.24 171.84 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 121.611 0.719 . . . . 0.0 111.874 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.0 t -119.79 121.98 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 O-C-N 120.597 -1.314 . . . . 0.0 111.681 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.646 ' HA ' ' HG2' ' A' ' 32' ' ' MET . 0.9 OUTLIER -48.75 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.038 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.752 ' H ' ' HA ' ' A' ' 32' ' ' MET . 5.7 m-20 97.53 157.03 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.426 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.22 102.31 2.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.848 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 45.99 37.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.973 0.416 . . . . 0.0 109.977 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 86.58 61.21 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.081 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 26' ' ' ASP . . . -146.63 176.24 25.64 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.406 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -55.76 -79.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.869 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.8 mtm -153.43 129.8 10.57 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 24' ' ' VAL . 0.4 OUTLIER -91.76 140.56 15.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.087 0.946 . . . . 0.0 112.162 -176.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.839 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 t -103.73 92.27 4.13 Favored Pre-proline 0 N--CA 1.422 -1.874 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.996 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -42.57 -16.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.242 3.295 . . . . 0.0 113.322 -178.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.133 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 4.0 mm-40 -90.92 -72.4 0.58 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.218 -1.355 . . . . 0.0 108.878 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' HD23 ' A' ' 39' ' ' LEU . 23.8 p -97.67 22.95 8.36 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.952 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 22.24 45.58 0.01 OUTLIER Glycine 0 CA--C 1.481 -2.057 0 CA-C-O 122.387 0.993 . . . . 0.0 114.511 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.076 HD11 HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -83.59 -174.19 5.15 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 112.86 -1.67 . . . . 0.0 107.873 177.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.82 ' HA ' ' O ' ' A' ' 32' ' ' MET . 63.3 t -136.99 151.33 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.076 HG23 HD11 ' A' ' 39' ' ' LEU . 54.0 t -148.55 132.76 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.421 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.6 -166.13 13.84 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.254 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.37 -81.26 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.633 0.254 . . . . 0.0 110.764 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 63.36 147.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.837 ' O ' ' N ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -123.87 -92.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER 27.06 -61.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.837 ' N ' ' O ' ' A' ' 45' ' ' VAL . 1.1 t70 80.07 66.07 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.28 138.87 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.974 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.17 69.5 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -154.2 84.22 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.28 18.79 11.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 63.01 134.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.857 0.361 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' THR . 0.8 OUTLIER -108.37 105.27 14.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -158.8 164.11 36.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -141.7 51.96 1.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.25 127.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -74.72 -176.29 2.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.38 -32.24 19.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.885 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -108.87 -30.42 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -58.97 -45.22 91.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.17 80.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.976 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 62.77 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.207 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 39.4 p-10 -90.76 101.72 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.77 130.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.632 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 4.3 mp -53.2 -50.73 80.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.359 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 10' ' ' LEU . 89.1 Cg_endo -93.47 -93.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.923 2.415 . . . . 0.0 112.461 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.555 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 4.9 mmp_? -135.47 -88.8 0.33 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.2 p 142.18 60.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.216 0.607 . . . . 0.0 110.725 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER 164.04 -166.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.679 0.276 . . . . 0.0 110.531 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.547 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -115.59 117.8 39.91 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-O 121.579 0.704 . . . . 0.0 112.616 177.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.97 58.94 6.53 Favored 'Trans proline' 0 CA--C 1.506 -0.923 0 C-N-CA 123.735 2.956 . . . . 0.0 107.225 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -175.2 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.162 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -136.39 85.91 25.29 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.316 171.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.11 -17.2 24.12 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.281 1.987 . . . . 0.0 111.106 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.38 -20.06 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.405 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.889 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -107.18 130.24 54.74 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 121.624 -0.673 . . . . 0.0 109.697 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -98.08 127.63 50.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.735 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 39' ' ' LEU . 4.4 mp -53.85 139.27 33.94 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -100.49 137.85 26.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.666 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 3.3 mm-40 -48.65 114.8 1.05 Allowed 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.668 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 7.5 t70 126.46 133.35 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -135.44 95.2 3.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 53.12 26.77 5.2 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 96.98 21.6 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.164 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' H ' ' H ' ' A' ' 27' ' ' TYR . . . -132.98 -102.47 0.81 Allowed Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.668 ' O ' ' CA ' ' A' ' 26' ' ' ASP . 20.5 m-20 -77.5 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.164 0.586 . . . . 0.0 111.771 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 mtm -108.27 133.08 52.99 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.423 0.63 . . . . 0.0 110.205 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.791 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -114.47 146.02 19.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.692 -177.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' O ' ' N ' ' A' ' 38' ' ' GLY . 14.1 t -98.49 108.74 49.57 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 5.3 Cg_endo -49.72 -14.52 0.77 Allowed 'Trans proline' 0 CA--C 1.517 -0.372 0 C-N-CA 122.657 2.238 . . . . 0.0 114.67 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.162 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 2.7 mm-40 -99.26 -53.31 3.27 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.245 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.78 ' SG ' ' HE1' ' A' ' 18' ' ' HIS . 4.6 p -93.51 -26.35 17.2 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 175.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.815 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 76.13 25.07 67.25 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.918 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -51.16 -158.01 0.0 OUTLIER 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.172 -1.014 . . . . 0.0 110.333 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 32' ' ' MET . 55.8 t -155.84 130.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.063 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 39' ' ' LEU . 92.4 t -143.2 149.84 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.355 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.45 157.36 15.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.599 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.28 -39.57 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.45 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.1 55.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.636 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -77.68 70.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.074 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 45' ' ' VAL . 38.9 mm -147.49 -73.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.693 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 53.87 175.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.271 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.3 t -155.99 139.57 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.72 -84.65 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.545 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.42 110.25 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -171.85 36.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m0 65.6 -73.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 62.17 90.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.98 -164.25 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 18.1 p90 -113.34 68.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.09 -178.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -101.16 155.41 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.63 -39.08 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.763 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.747 0.308 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 -32.25 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 p -109.25 -31.57 7.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 154.91 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -144.2 -75.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mt -172.81 152.64 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.23 83.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.35 72.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -60.94 -62.94 4.96 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 85.7 Cg_endo -79.16 -169.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.55 2.167 . . . . 0.0 112.156 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.669 ' HG3' HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -92.24 122.0 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 110.305 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 14' ' ' THR . 13.3 p -58.09 -40.98 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.032 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.757 HG23 ' HA ' ' A' ' 22' ' ' ILE . 6.9 m -166.87 -124.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.729 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -127.41 129.9 23.8 Favored Pre-proline 0 N--CA 1.462 0.129 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 177.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.29 -32.19 81.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.468 2.112 . . . . 0.0 110.85 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 3.3 t-20 -84.2 -32.7 24.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.136 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -133.07 89.11 34.61 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.097 177.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' O ' HG21 ' A' ' 14' ' ' THR . 18.3 Cg_endo -57.38 -17.15 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.38 2.053 . . . . 0.0 111.38 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.7 -56.49 3.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.944 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -72.71 100.4 2.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.711 0.767 . . . . 0.0 112.133 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.757 ' HA ' HG23 ' A' ' 14' ' ' THR . 0.5 OUTLIER -71.06 129.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.341 179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 39' ' ' LEU . 4.6 mp -52.03 142.69 15.4 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.264 0.484 . . . . 0.0 111.238 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -99.86 137.45 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 O-C-N 121.646 -0.659 . . . . 0.0 110.754 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -47.17 177.91 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.128 -178.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -3.29 108.55 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.002 -1.453 . . . . 0.0 113.911 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 2.5 p90 -102.68 -46.22 4.79 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.213 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.584 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -144.87 91.17 2.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 81.2 4.19 1.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.653 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 114.59 166.56 15.47 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.318 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.9 m-20 97.7 154.23 0.02 OUTLIER 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 85.0 mtp -76.23 157.86 32.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 110.984 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.044 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.4 OUTLIER -139.24 136.58 41.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.828 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.6 t -98.93 105.5 31.88 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.2 Cg_endo -51.05 -13.25 0.89 Allowed 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 122.798 2.332 . . . . 0.0 114.603 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.136 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 58.0 mm-40 -99.65 -52.64 3.41 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.617 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.409 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 3.9 p -94.29 -26.53 16.56 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.828 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 77.53 29.7 54.97 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 114.636 -1.166 . . . . 0.0 113.374 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 23' ' ' LEU . 1.5 pp -56.61 -158.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.941 -1.129 . . . . 0.0 110.197 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.827 ' HA ' ' O ' ' A' ' 32' ' ' MET . 46.0 t -163.51 135.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 123.637 0.586 . . . . 0.0 109.83 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.669 HG11 ' HG3' ' A' ' 12' ' ' ARG . 15.7 t -138.01 144.46 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.115 0.483 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.87 148.36 23.62 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.642 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.16 85.02 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 -38.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.454 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 47' ' ' ASP . 15.8 t 70.64 -64.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.956 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD11 ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER 42.86 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.805 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 46' ' ' ILE . 19.2 t0 61.59 44.5 9.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 48' ' ' VAL . 10.7 p -78.51 71.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.13 -76.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.541 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t 54.34 27.9 8.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.08 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -115.86 41.78 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 64.1 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.986 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.13 115.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.918 0.389 . . . . 0.0 110.975 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -161.49 172.53 16.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 33.9 p90 -107.69 18.3 21.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.4 -169.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.002 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -171.56 -169.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -67.02 -66.42 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.807 0.337 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -82.83 103.67 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 p -141.93 -48.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.48 115.7 16.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -110.24 -74.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 161.09 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -139.0 66.14 1.43 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.762 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.95 58.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -67.88 -59.62 6.36 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 10' ' ' LEU . 84.0 Cg_endo -84.96 -167.4 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.722 2.282 . . . . 0.0 112.162 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 4.5 mtm-85 -77.51 -170.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.402 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 14' ' ' THR . 2.5 t -137.02 -32.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER 157.38 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.049 0.539 . . . . 0.0 109.642 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -99.52 136.83 20.25 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 89.6 Cg_endo -75.84 31.99 0.39 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 123.392 2.728 . . . . 0.0 110.525 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 15' ' ' CYS . 1.6 t30 -155.3 -33.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.699 -1.591 . . . . 0.0 106.856 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.207 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.4 87.29 27.74 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.4 175.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' O ' HG21 ' A' ' 14' ' ' THR . 36.0 Cg_endo -64.2 -1.83 4.14 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.171 1.914 . . . . 0.0 111.218 177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.03 -28.1 8.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.869 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -93.47 66.4 3.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 122.672 1.225 . . . . 0.0 110.845 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -41.59 104.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 110.954 -2.839 . . . . 0.0 112.052 -178.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' SG ' ' A' ' 15' ' ' CYS . 4.3 mp -41.94 144.84 0.39 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 118.377 0.535 . . . . 0.0 111.998 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.7 t -101.38 148.61 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 O-C-N 120.354 -1.466 . . . . 0.0 109.737 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.626 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 5.4 mt-10 -73.21 93.72 1.89 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.456 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.795 ' H ' ' HA ' ' A' ' 32' ' ' MET . 18.7 p30 150.72 -162.85 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.023 0.827 . . . . 0.0 113.06 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.619 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 72.3 t80 89.52 156.1 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 123.826 0.85 . . . . 0.0 112.142 178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -15.2 85.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.456 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 28' ' ' ARG . . . 130.53 -14.26 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.989 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.61 72.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.93 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -80.67 -107.09 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.201 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 1.057 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 34.3 mtp -145.62 149.69 34.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CD1' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -123.97 127.58 73.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.756 0.788 . . . . 0.0 111.557 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.826 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 t -90.12 94.36 0.57 Allowed Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.233 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 10.2 Cg_endo -48.51 -6.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.525 2.817 . . . . 0.0 114.942 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.207 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -98.41 -61.11 1.42 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.522 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' H ' ' CE1' ' A' ' 18' ' ' HIS . 7.2 p -89.99 -29.87 18.16 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 79.83 30.57 42.92 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.495 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 41' ' ' VAL . 0.5 OUTLIER -64.68 -156.02 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.057 ' HA ' ' O ' ' A' ' 32' ' ' MET . 42.9 t -153.91 149.13 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 39' ' ' LEU . 50.7 t -151.4 140.79 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.604 1.093 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ARG . . . 120.3 22.89 3.04 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -27.77 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 113.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.46 43.82 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER 44.19 -165.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.397 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 47' ' ' ASP . 7.6 tp -157.79 -44.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 46' ' ' ILE . 38.7 t70 -68.63 114.6 7.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.59 145.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.81 -167.27 12.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t 59.75 29.63 19.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.04 18.78 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.52 -64.97 0.29 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.803 0.335 . . . . 0.0 111.175 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 70.71 86.2 0.13 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.742 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 m -122.74 158.43 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.79 45.4 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m 67.64 161.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.816 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.22 -170.29 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.53 -31.8 11.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.85 0.357 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -88.11 -26.38 22.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -94.13 44.64 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.07 147.37 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.89 -79.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -115.93 -9.21 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.378 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER 87.39 -23.2 0.13 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.779 0.432 . . . . 0.0 111.575 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.48 145.44 0.24 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 111.249 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -77.8 -52.51 1.62 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.945 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 10' ' ' LEU . 96.6 Cg_endo -80.65 -166.79 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.583 2.189 . . . . 0.0 112.399 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.524 ' HE ' HG11 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -125.38 130.89 52.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.009 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -71.64 124.48 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.25 174.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -80.9 132.35 57.47 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.66 -4.99 15.76 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.727 2.284 . . . . 0.0 111.306 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.0 -15.5 9.28 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.151 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -142.03 88.55 9.22 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-O 121.733 0.777 . . . . 0.0 109.017 175.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.5 48.23 1.53 Allowed 'Trans proline' 0 CA--C 1.51 -0.721 0 C-N-CA 123.635 2.89 . . . . 0.0 109.03 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' HIS . 1.5 m-20 -157.73 -53.12 0.07 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.302 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.074 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -74.74 103.48 5.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.155 0.979 . . . . 0.0 110.509 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.75 108.27 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 112.572 -2.103 . . . . 0.0 113.412 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.1 mp -48.07 138.74 8.93 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 32' ' ' MET . 15.4 t -91.3 145.68 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.886 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.663 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.8 mm-40 -72.32 85.97 1.1 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.043 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.663 ' CB ' ' O ' ' A' ' 25' ' ' GLU . 14.5 t70 114.46 104.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.659 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -86.11 115.57 23.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 43.2 mtm180 34.32 41.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.141 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 92.88 41.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.738 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 27' ' ' TYR . . . -140.03 -129.52 2.59 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.133 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.65 ' HB2' HG12 ' A' ' 40' ' ' VAL . 0.9 OUTLIER -106.2 -162.98 0.89 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.79 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.774 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 32.2 mtt -57.65 108.2 0.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' HB ' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -96.3 120.87 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.883 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.825 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.9 t -86.3 101.41 1.95 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.9 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 6.5 Cg_endo -47.1 -13.5 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.037 2.491 . . . . 0.0 114.55 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.151 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 3.0 mm-40 -99.8 -53.44 3.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.299 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.7 p -97.11 -17.09 20.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.825 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 70.28 27.2 73.12 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.46 -1.246 . . . . 0.0 113.351 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.8 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -73.26 140.35 46.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.691 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 31' ' ' ASP . 21.9 t -98.37 121.97 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.8 t -123.65 127.51 74.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.614 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 168.2 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.523 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -126.66 114.41 17.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 110.695 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -117.27 37.94 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 p -55.69 -25.37 18.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.433 HD13 ' C ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -127.93 122.76 59.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 110.818 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -53.87 -79.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.197 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.2 p -179.08 41.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.985 0.421 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.94 -97.17 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.455 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 p -176.89 174.04 1.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.71 0.29 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' TRP . 19.4 tp10 -171.86 35.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 48.9 m0 68.33 -59.54 0.44 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 52' ' ' TRP . 2.2 tmt_? 80.54 85.42 0.05 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -150.71 -172.21 4.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' H ' HG22 ' A' ' 54' ' ' THR . 8.4 p90 -107.29 96.27 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m 60.53 -177.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.81 -168.85 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -153.39 -45.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.817 0.342 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -81.32 -30.71 33.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -71.68 -76.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.96 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.71 170.5 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 -52.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.84 145.49 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.95 43.88 2.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.697 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.73 135.96 50.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . 3.4 tm? -178.54 -55.97 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.844 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 56.7 Cg_endo -71.89 -88.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.005 1.803 . . . . 0.0 112.474 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.861 ' O ' HG12 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -147.48 -81.39 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.334 0.111 . . . . 0.0 110.823 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.1 37.67 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 179.428 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 65.0 170.67 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.711 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -68.16 127.44 93.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.901 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.44 -15.83 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.612 2.208 . . . . 0.0 110.031 177.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -29.96 12.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.112 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.0 87.24 30.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.65 176.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.23 48.4 1.77 Allowed 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.116 2.544 . . . . 0.0 108.696 176.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 18' ' ' HIS . 15.4 m-20 -160.37 -21.26 0.06 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.297 -178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.983 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -110.92 113.1 25.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 14' ' ' THR . 3.0 mm -76.3 123.97 33.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.759 HD13 ' NH1' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -52.49 120.93 6.15 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.7 t -87.32 152.43 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 2.1 mm-40 -86.96 123.17 31.78 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' CG ' ' HA2' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 91.15 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.485 175.386 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.743 ' CE1' HG11 ' A' ' 40' ' ' VAL . 2.7 p90 -81.2 96.57 7.27 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.198 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.78 32.62 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.02 -58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.927 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.597 ' HA2' ' CG ' ' A' ' 26' ' ' ASP . . . 160.6 167.92 21.78 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.431 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 43' ' ' ASP . 0.5 OUTLIER 92.46 -136.3 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.928 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.43 140.74 50.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.313 0.245 . . . . 0.0 110.705 -179.239 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -128.66 132.19 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.767 0.827 . . . . 0.0 109.34 -178.421 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.816 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.7 t -86.31 105.14 6.83 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.7 Cg_endo -49.12 -15.98 0.83 Allowed 'Trans proline' 0 CA--C 1.515 -0.464 0 C-N-CA 122.567 2.178 . . . . 0.0 114.583 -177.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.112 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.82 -48.57 4.43 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.503 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.7 p -99.22 -18.32 17.69 Favored 'General case' 0 C--O 1.214 -0.795 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.816 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 72.67 30.1 64.55 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 114.162 -1.381 . . . . 0.0 114.161 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.759 HD11 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -74.19 140.76 45.33 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.5 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 32' ' ' MET . 31.4 t -108.84 143.24 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.447 -178.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.653 ' CG2' ' CD1' ' A' ' 39' ' ' LEU . 1.7 t -153.8 113.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' ASP . . . 152.94 -172.74 31.94 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.237 -1.458 . . . . 0.0 113.511 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.78 ' HB2' ' OD1' ' A' ' 31' ' ' ASP . 28.5 t70 66.76 50.73 1.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.11 0.481 . . . . 0.0 110.184 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.9 18.14 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.277 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER 57.88 -64.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 122.843 0.457 . . . . 0.0 112.035 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' ARG . 35.5 mm 84.39 45.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.18 98.04 7.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.86 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 49' ' ' GLY . 16.7 t -94.31 159.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 48' ' ' VAL . . . -111.28 34.02 5.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.617 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 180.0 42.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.96 4.83 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.525 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.9 m0 62.73 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.661 0.267 . . . . 0.0 111.01 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? 60.72 115.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -149.03 -170.92 3.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.807 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 54' ' ' THR . 8.1 p90 -114.91 51.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.98 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m 58.72 -172.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -110.69 177.34 4.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -153.03 -58.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.832 0.349 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 4' ' ' THR . 4.7 m -137.74 27.44 2.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.067 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 3' ' ' SER . 39.9 p -158.26 30.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.29 118.36 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.2 -71.72 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.67 -165.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.856 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.65 -45.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.227 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 10' ' ' LEU . . . -90.44 -43.72 10.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.362 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER 164.73 165.81 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.017 -179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 10' ' ' LEU . 19.4 Cg_endo -58.41 96.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.373 2.049 . . . . 0.0 112.242 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.66 115.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.408 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 14' ' ' THR . 5.9 p -62.83 -144.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.687 ' N ' HG13 ' A' ' 13' ' ' VAL . 3.1 p -77.94 -89.91 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.824 0.738 . . . . 0.0 109.461 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' ' CD2' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -124.34 118.75 26.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.028 173.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -82.19 64.12 8.31 Favored 'Trans proline' 0 CA--C 1.496 -1.382 0 C-N-CA 123.351 2.701 . . . . 0.0 106.859 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -179.97 -42.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.18 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -134.91 86.07 33.51 Favored Pre-proline 0 CA--C 1.52 -0.177 0 CA-C-N 113.377 -1.738 . . . . 0.0 110.155 172.221 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.21 -32.35 93.29 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.399 2.066 . . . . 0.0 111.433 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -74.64 -17.9 60.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -112.41 108.57 17.77 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.55 -0.719 . . . . 0.0 110.762 179.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 1.4 mt -72.23 129.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD21 ' HG ' ' A' ' 39' ' ' LEU . 1.2 mp -57.55 124.17 18.09 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' ILE . 32.9 t -91.37 148.22 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.81 0.814 . . . . 0.0 111.957 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 1.7 tm-20 -63.13 113.47 3.17 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.712 -178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.673 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 30.1 m-20 97.84 179.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.735 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.833 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 3.2 t80 -173.16 -75.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.367 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' NH1' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -125.64 -43.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.522 179.027 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.66 18.06 11.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.269 178.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASP . . . 90.27 -173.27 38.97 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.191 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 14.7 m-20 98.07 -135.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.215 0.606 . . . . 0.0 109.551 -178.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.88 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.5 mtp -132.43 116.58 16.98 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.833 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -105.53 132.15 53.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 123.106 0.562 . . . . 0.0 110.721 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.786 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.9 t -90.82 104.87 10.28 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 8.1 Cg_endo -49.2 -14.29 0.48 Allowed 'Trans proline' 0 CA--C 1.519 -0.27 0 C-N-CA 122.726 2.284 . . . . 0.0 114.74 -177.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.18 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 57.3 mm-40 -100.75 -48.76 4.38 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.573 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.2 p -98.7 -19.62 17.4 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.826 ' HA2' ' CD1' ' A' ' 33' ' ' ILE . . . 75.03 29.14 61.14 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.441 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.666 ' CD1' HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -75.25 136.01 40.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.137 -178.563 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.5 t -97.31 142.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.946 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 39' ' ' LEU . 1.6 t -144.36 122.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.132 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.91 160.59 31.8 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.122 177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.686 ' O ' ' O ' ' A' ' 44' ' ' ARG . 31.4 m-20 -116.75 -92.76 0.51 Allowed 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.686 ' O ' ' O ' ' A' ' 43' ' ' ASP . 4.7 ptp85 42.59 146.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 44' ' ' ARG . 14.7 p 179.06 -24.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.009 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -39.24 148.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.786 0.327 . . . . 0.0 111.865 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.79 149.35 22.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.77 -58.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.958 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.2 97.08 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.59 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 t -177.04 -50.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -79.5 61.6 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 19.6 m0 66.79 -71.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.23 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.2 24.49 9.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.951 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -164.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 41.4 p90 -71.53 63.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.6 m 58.86 172.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -109.82 174.93 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.54 -47.01 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.827 0.346 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -75.74 -42.76 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.79 60.86 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.82 170.9 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -165.03 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.12 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.14 72.16 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.789 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -54.09 163.47 0.78 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 10' ' ' LEU . . . 54.34 52.06 13.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.417 -179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 9' ' ' ALA . 10.4 tp -15.65 -66.35 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.396 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 10' ' ' LEU . 36.8 Cg_endo -69.46 -77.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.047 1.831 . . . . 0.0 112.198 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 178.81 0.38 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.494 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' THR . 3.5 t -130.33 2.81 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.519 HG22 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -170.61 172.89 5.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.497 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER -76.6 126.58 85.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.562 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.17 -15.61 50.37 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.771 2.314 . . . . 0.0 111.123 178.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -107.43 -18.41 13.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.123 ' NE2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -146.51 86.7 6.73 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.712 0.767 . . . . 0.0 109.477 175.524 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 18' ' ' HIS . 9.4 Cg_endo -55.58 -16.27 14.18 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.851 2.367 . . . . 0.0 111.108 179.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.75 -50.86 7.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.547 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.929 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . . . -71.74 104.89 3.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.198 0.523 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD13 HG22 ' A' ' 14' ' ' THR . 3.6 mm -76.22 99.61 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.105 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 39' ' ' LEU . 1.8 mp -36.25 139.91 0.15 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.111 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' MET . 5.7 t -99.37 140.83 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 O-C-N 121.142 -0.974 . . . . 0.0 110.819 178.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 0.8 OUTLIER -78.42 82.02 4.72 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.341 179.162 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' O ' ' O ' ' A' ' 27' ' ' TYR . 50.5 p-10 -167.51 -124.58 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 119.311 -0.955 . . . . 0.0 112.954 -176.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.776 ' O ' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 19.42 132.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.402 1.081 . . . . 0.0 113.821 179.618 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 74.04 51.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.768 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.37 64.69 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.167 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 31' ' ' ASP . . . 70.58 170.87 9.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.122 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.729 ' OD1' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER 96.4 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.766 0.794 . . . . 0.0 111.762 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.832 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 29.7 mtp -56.44 145.53 27.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.756 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.59 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -150.42 136.9 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -179.267 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.825 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.7 t -99.98 105.1 33.06 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.82 -5.73 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.282 1.988 . . . . 0.0 114.109 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.123 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 43.4 mm-40 -102.04 -51.82 3.31 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.763 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.714 ' SG ' HD23 ' A' ' 39' ' ' LEU . 5.0 p -95.9 -30.13 13.81 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 81.31 30.57 36.82 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.376 -1.284 . . . . 0.0 114.115 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.2 pp -62.41 -148.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.858 ' O ' HD12 ' A' ' 39' ' ' LEU . 71.5 t -156.43 165.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG23 HD22 ' A' ' 23' ' ' LEU . 3.2 t -169.73 139.57 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 120.829 1.65 . . . . 0.0 110.033 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.42 146.7 14.41 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.835 178.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.28 127.43 29.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -83.79 -52.57 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.668 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.3 t -58.35 121.38 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 46' ' ' ILE . 18.3 tt -175.21 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -92.94 -177.97 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.9 -66.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 178.76 39.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -64.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.14 3.2 31.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.487 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 66.72 -72.79 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.753 0.311 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.05 94.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.939 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -144.7 -166.26 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' H ' HG22 ' A' ' 54' ' ' THR . 26.0 p90 -93.81 47.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m 61.29 176.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.29 148.57 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.943 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.45 -42.19 11.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.32 -61.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.9 p -64.92 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.55 -165.56 0.21 Allowed 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 110.773 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -175.72 169.76 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.4 tp -52.54 95.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 -157.62 0.32 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.285 -179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' O ' HD12 ' A' ' 10' ' ' LEU . . . -45.27 -77.13 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.08 60.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.52 150.69 17.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.315 . . . . 0.0 112.421 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.44 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.482 ' C ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -114.27 -173.94 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.8 p 81.66 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.533 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -129.43 124.77 22.19 Favored Pre-proline 0 C--N 1.332 -0.164 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.25 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 61.04 7.02 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.757 2.972 . . . . 0.0 107.172 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.423 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 7.0 t-20 -179.55 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 -177.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.135 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -135.88 82.75 36.63 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.749 173.083 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.21 -19.1 48.1 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.173 1.916 . . . . 0.0 111.466 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.09 -18.82 31.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.907 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.849 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -113.1 94.15 4.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.118 0.485 . . . . 0.0 109.703 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.781 HG23 ' HA ' ' A' ' 14' ' ' THR . 5.2 mt -67.41 128.51 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.766 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 32' ' ' MET . 5.3 mp -51.55 147.83 5.88 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.805 0.812 . . . . 0.0 111.584 179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.789 HG12 ' H ' ' A' ' 25' ' ' GLU . 3.8 t -80.11 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.86 ' O ' ' HA ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -86.57 -83.3 0.19 Allowed 'General case' 0 C--O 1.19 -2.026 0 CA-C-N 120.071 1.305 . . . . 0.0 111.068 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 27' ' ' TYR . 16.8 m-20 -84.81 -142.35 0.08 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.755 0.312 . . . . 0.0 110.874 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.731 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 1.2 t80 153.52 99.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 ttt180 67.82 38.16 2.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.321 -177.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 28' ' ' ARG . . . 71.07 45.9 0.48 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -177.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.32 -139.68 4.57 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -177.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -112.69 -170.04 1.59 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.95 -1.125 . . . . 0.0 111.641 -178.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.866 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 49.5 mtp -52.3 112.61 0.84 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 112.226 -178.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.852 HD13 ' N ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -97.64 144.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.919 179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.852 ' N ' HD13 ' A' ' 33' ' ' ILE . 4.7 t -104.71 106.33 54.33 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -52.98 -12.01 1.8 Allowed 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.746 2.297 . . . . 0.0 114.14 -177.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.135 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -100.35 -51.56 3.61 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.015 179.402 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' HD23 ' A' ' 39' ' ' LEU . 3.8 p -95.01 -29.88 14.39 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.812 ' N ' ' O ' ' A' ' 34' ' ' CYS . . . 81.69 30.52 35.73 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.871 178.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD11 HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -61.01 -152.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.091 -1.054 . . . . 0.0 110.07 -179.302 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.866 ' HA ' ' O ' ' A' ' 32' ' ' MET . 83.4 t -162.89 135.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 123.994 0.809 . . . . 0.0 109.794 178.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG23 HD11 ' A' ' 39' ' ' LEU . 86.9 t -146.56 154.9 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.566 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 41' ' ' VAL . . . 101.55 30.25 5.95 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.581 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.86 111.21 17.68 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 153.49 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 111.232 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' ILE . 1.0 OUTLIER -103.96 -64.26 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.175 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 70.09 168.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.293 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -127.25 78.37 1.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.678 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.4 t -72.16 145.29 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -170.77 -162.65 23.46 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.487 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.77 6.82 5.45 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -153.65 19.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.59 0.234 . . . . 0.0 111.265 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CH2' ' ND2' ' A' ' 57' ' ' ASN . 6.2 m-90 68.47 1.55 2.99 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 46.25 59.34 3.86 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.528 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.22 160.66 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.042 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -82.43 135.45 35.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.834 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 m 64.04 134.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' ND2' ' CH2' ' A' ' 52' ' ' TRP . 32.8 t-20 -81.21 155.17 26.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.17 -53.76 2.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.788 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -93.29 -35.63 12.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 p -67.99 -31.46 71.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -128.63 154.22 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -100.06 -32.54 10.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.25 142.83 50.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.82 -43.45 2.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.87 153.69 27.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.079 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.12 -50.28 1.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.917 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 10' ' ' LEU . 90.5 Cg_endo -83.46 -164.35 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.579 2.186 . . . . 0.0 111.927 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -99.08 31.49 3.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.692 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 14' ' ' THR . 0.8 OUTLIER 65.14 -58.44 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.873 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 178.72 -176.26 0.22 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.443 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.653 ' HB3' ' H ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -76.58 132.7 71.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.033 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 15' ' ' CYS . 26.6 Cg_endo -61.64 -24.14 77.38 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.585 2.19 . . . . 0.0 110.909 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB3' ' ND1' ' A' ' 18' ' ' HIS . 2.9 t-20 -95.82 -38.48 10.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 1.113 ' CD2' ' HB2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -127.04 88.38 54.52 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.849 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.635 ' O ' HG21 ' A' ' 14' ' ' THR . 20.6 Cg_endo -59.68 -11.19 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.269 1.98 . . . . 0.0 111.289 178.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -47.91 7.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.393 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.996 ' HB3' ' HD2' ' A' ' 18' ' ' HIS . . . -78.71 104.64 9.46 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 123.163 1.459 . . . . 0.0 111.737 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -71.85 97.9 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 110.781 -2.918 . . . . 0.0 114.035 -177.427 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD21 HD11 ' A' ' 39' ' ' LEU . 1.4 mp -34.39 138.64 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.406 178.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 32' ' ' MET . 6.5 t -97.63 142.27 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.551 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.236 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.22 81.98 2.36 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.792 -179.426 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER 168.34 81.03 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.633 -179.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -104.9 114.16 28.19 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.966 0.791 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 62.9 mtm-85 25.23 40.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ARG . . . 167.19 -78.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.616 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.66 40.17 0.12 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.137 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -128.64 178.89 6.01 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.056 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.799 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.58 151.3 46.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.673 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -149.06 134.35 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.13 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.847 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 4.4 t -93.69 107.18 25.27 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.21 -0.306 . . . . 0.0 110.334 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 34' ' ' CYS . 11.8 Cg_endo -53.24 -11.4 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.981 2.454 . . . . 0.0 114.263 -178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 1.113 ' HB2' ' CD2' ' A' ' 18' ' ' HIS . 66.1 mm-40 -100.72 -53.3 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.835 178.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' HD23 ' A' ' 39' ' ' LEU . 4.8 p -96.07 -26.42 15.52 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.847 ' HA2' ' O ' ' A' ' 34' ' ' CYS . . . 77.77 29.68 54.26 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.855 177.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 40' ' ' VAL . 1.3 pp -58.98 -149.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.842 ' O ' HD12 ' A' ' 39' ' ' LEU . 72.9 t -157.42 163.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 39' ' ' LEU . 45.9 t -164.64 138.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 120.421 1.464 . . . . 0.0 109.17 177.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 143.96 15.74 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.274 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.4 -45.5 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.97 133.16 51.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.7 135.53 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.291 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -117.48 -102.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.641 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.692 ' H ' HG23 ' A' ' 46' ' ' ILE . 2.1 t0 41.75 -156.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.171 0.441 . . . . 0.0 111.096 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.05 123.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.018 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.51 21.07 33.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.36 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.86 -156.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.584 0.23 . . . . 0.0 110.602 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 66.8 139.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.401 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -115.1 -30.36 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.117 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 69.02 94.41 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.983 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.401 HG23 ' HE3' ' A' ' 52' ' ' TRP . 0.8 OUTLIER -139.71 105.47 5.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 55' ' ' PHE . 40.8 p90 -71.22 65.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 63.51 -169.59 0.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.83 145.4 44.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.782 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -25.19 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.914 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_